Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
IDI2	IPPI2	ENSG00000148377	"Isopentenyl-diphosphate delta isomerase 2"	Q9BXS1	10	1018907-1025859	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	125	"skeletal muscle: 141.6"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;NB-4: 2.6;NTERA-2: 1.5;SK-MEL-30: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																														"unprognostic (6.69e-3)"	"unprognostic (4.05e-2)"				"unprognostic (1.64e-1)"				1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	141.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.5	0.1	0.0	0.7	0.0	0.8	0.1	0.0	1.0	0.0	0.0	0.4	0.4	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.7	0.0	0.5	0.0	0.3	0.9	1.3	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	2.6	1.5	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.4	1.0	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUPD1	DUSP27	ENSG00000188716	"Dual specificity phosphatase and pro isomerase domain containing 1"	Q68J44	10	75037836-75058514	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"skeletal muscle: 38.9"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042964	Uncertain									"HPA042964: AB_10795764"						"unprognostic (1.05e-2)"				"unprognostic (1.77e-1)"					"unprognostic (2.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.5	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0										
MYH1	"MGC133384, MYHa, MyHC-2X/D, MYHSA1"	ENSG00000109061	"Myosin heavy chain 1"	P12882	17	10492307-10518543	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"skeletal muscle: 428.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;U-2 OS: 2.2"	"Cancer enriched"	"Detected in single"	45	"head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA001349, CAB010759"	Enhanced					49000000	49000000			"CAB010759: AB_477248, HPA001349: AB_1079437"	"unprognostic (2.87e-2)"					"unprognostic (3.27e-3)"		"unprognostic (1.91e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.31e-2)"		"unprognostic (5.63e-3)"	"unprognostic (9.85e-4)"	"unprognostic (1.92e-1)"		"unprognostic (4.58e-2)"	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	428.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC30		ENSG00000206422	"Leucine rich repeat containing 30"	A6NM36	18	7231125-7232047	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	30	"skeletal muscle: 18.7"	"Cell line enriched"	"Detected in single"	12	"SH-SY5Y: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041039	Uncertain									"HPA041039: AB_2677270"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.2	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"skeletal muscle: 15.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;U-2 OS: 1.4"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"amygdala: 0.9"	HPA001349	Supported					34000000	34000000			"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SMTNL1	CHASM	ENSG00000214872	"Smoothelin like 1"	A8MU46	11	57542641-57550274	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"skeletal muscle: 118.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;HDLM-2: 2.8;U-266/70: 5.0;U-266/84: 2.8"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																		"unprognostic (1.35e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.04e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.44e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		1.4	0.0	118.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	1.2	0.8	4.3	1.7	0.7	2.4	0.5	0.1	0.2	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.5	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.9	0.0	0.1	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.9	1.1	0.7	0.1	1.6	0.4	0.8	0.0	0.0	0.0	0.9	0.6	0.1	0.5	0.3	0.0	0.0	0.2	0.4	0.5	0.0	5.0	2.8	0.1	0.5	1.3	0.0	2.5	1.2	2.7	1.8	1.4	1.9	1.1	1.2	1.9	0.8	1.2	2.4	1.8	4.3	0.7	1.7	0.8	0.7	0.5										
ACTN3		ENSG00000248746	"Actinin alpha 3 (gene/pseudogene)"	Q08043	11	66546395-66563329	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skeletal muscle: 185.5"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 16.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA006035	Uncertain		Uncertain	"Actin filaments"		29000000	29000000	"Actin filaments"	"Actin filaments"	"HPA006035: AB_1078095"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-4)"	"unprognostic (1.40e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.71e-9)"	"unprognostic (2.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.48e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	1.0	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	185.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.7	1.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1										
PPP1R27	"DYSFIP1, toonin"	ENSG00000182676	"Protein phosphatase 1 regulatory subunit 27"	Q86WC6	17	81833492-81835050	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"skeletal muscle: 211.0"	"Group enriched"	"Detected in some"	23	"HL-60: 62.4;THP-1: 121.0"	"Cancer enriched"	"Detected in single"	10	"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048632	Uncertain									"HPA048632: AB_2680469"	"unprognostic (3.35e-2)"	"unprognostic (1.12e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.98e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.30e-1)"	1.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.7	0.0	0.0	1.7	0.0	211.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	9.6	1.2	0.0	0.0	0.8	0.4	3.2	0.4	0.7	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.4	0.3	0.3	0.2	0.3	0.4	0.2	0.2	0.3	0.8	0.3	0.4	3.2	0.7	0.3	0.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYADML2	LOC255275	ENSG00000185105	"Myeloid associated differentiation marker like 2"	A6NDP7	17	81939645-81947233	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	20	"skeletal muscle: 44.5"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 8.2"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA041856, HPA048476"	Uncertain									"HPA041856: AB_2677709, HPA048476: AB_2680410"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.90e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (4.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.4	2.2	0.0	0.0			0.2	0.0	0.0	0.5	0.0	0.0	1.5	0.6	1.5	0.0	0.0	0.0	0.0	1.1		0.0	0.1	0.0	0.0	0.0		0.3	0.0		0.3	0.0	44.5	0.0	0.2	0.0	0.1	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.3	1.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.1	0.6	0.5	0.0	0.4	0.1	0.0	0.2	8.2	0.6	0.2	0.2	0.6	0.2	0.0	0.0	0.3	0.7	0.2	0.0	1.5	1.1	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANKRD23	"DARP, FLJ32449, MARP3"	ENSG00000163126	"Ankyrin repeat domain 23"	Q86SG2	2	96824526-96857934	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 184.5"	"Cell line enriched"	"Detected in some"	8	"Karpas-707: 29.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.2"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA036201	Approved		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	Nucleoplasm	"HPA036201: AB_10673347"	"unprognostic (2.48e-1)"	"unprognostic (7.83e-4)"	"unprognostic (4.93e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.81e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-6)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.70e-4)"	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.7	0.0	0.1	2.2	0.1	184.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	12.2	0.9	0.1	0.1	0.4	0.2	0.5	0.0	0.9	1.2	0.4	0.3	0.5	0.3	0.6	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.2	0.1	0.8	0.7	0.3	0.4	0.1	0.1	0.5	1.3	0.2	0.2	0.4	0.0	0.1	0.6	29.0	0.2	0.7	0.3	0.6	0.3	0.2	1.0	0.0	3.6	0.1	0.6	1.0	0.1	0.2	0.5	0.0	0.8	0.0	0.2	0.3	0.4	0.5	0.0	1.3	0.4	0.2	0.3	0.8	0.3	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.9	0.0	0.2	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CHRNA10		ENSG00000129749	"Cholinergic receptor nicotinic alpha 10 subunit"	Q9GZZ6	11	3665587-3671384	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 33.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"olfactory region: 8.9"	"Not detected"	"Not detected"														"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.90e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.39e-3)"	0.2	0.2	0.2	0.4	0.3	0.2	0.1	1.1	0.1	0.2	0.2			0.4	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.3	0.6	0.4	0.3	0.1		0.3	0.1	0.0	0.7	0.1		0.7	0.1		0.3	0.1	33.6	0.4	0.2	0.1	0.0	1.0	0.2	0.3			0.5		0.1	0.1	0.0	0.3	0.3	2.2	0.6	0.2	1.0	0.2	1.4	1.5	2.1	2.8	0.9	0.3	1.4	1.7	0.4	1.3	1.3	1.1	2.5	2.5	1.0	0.8	3.1	1.6	0.9	1.1	1.6	5.2	0.7	3.9	0.5	1.2	0.6	2.7	0.9	1.0	0.9	0.3	0.8	2.0	0.6	1.0	0.4	1.5	4.1	2.9	2.0	2.7	0.9	0.4	1.0	2.0	1.9	0.8	0.9	0.9	1.5	0.6	3.2	0.7	1.8	2.3	1.3	2.1	0.7	1.7	1.3	0.9	1.3	1.2	0.0	0.4	0.4	1.0	0.0	0.3	0.0	0.8	0.2	0.1	0.3	0.4	0.5	2.2	0.2	0.6	0.3	0.6	0.2										
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Cell line enriched"	"Detected in many"	4	"HDLM-2: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	Nucleoplasm	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.0	2.0	1.7	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.0	0.3	0.4	2.2	0.8	0.4	0.8	17.8	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.6	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.4	1.6	4.2	0.6	1.1	0.6	1.2	1.2	0.5	0.9	0.7	0.2	1.1	0.4	0.3	1.4	0.6	1.2	1.6	1.7	0.8	0.3	1.1	0.6	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"skeletal muscle: 347.5"	"Group enriched"	"Detected in some"	32	"HEL: 23.3;RH-30: 39.2"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004967, HPA021775, HPA026700"	Enhanced					31000000	31000000			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favourable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	18.0	0.4	0.2	0.1	0.2	0.5	0.6	0.2	0.1	0.5	0.3	0.0	0.1	0.1	0.6	29.0	9.5	1.0	0.2	1.3	0.2	0.1	0.2	0.2	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	6.6	0.0	0.0	5.5	0.2	347.5	0.3	0.4	1.4	0.1	0.1	0.3	0.5	0.0	0.0	0.3	14.1	3.4	0.7	0.5	0.5	1.8	0.0	0.0	0.0	0.8	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	23.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0
IGFN1	"DKFZp434B1231, EEF1A2BP1"	ENSG00000163395	"Immunoglobulin-like and fibronectin type III domain containing 1"	Q86VF2	1	201190825-201228952	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skeletal muscle: 118.8"	"Cell line enriched"	"Detected in some"	9	"HeLa: 36.8"	"Group enriched"	"Detected in some"	11	"renal cancer: 1.8;thyroid cancer: 8.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050415	Enhanced		Approved	"Midbody ring"				"Midbody ring"	"Midbody ring"	"HPA050415: AB_2681120"	"unprognostic (2.09e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavourable (1.27e-8)"	"unprognostic (3.55e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.42e-2)"	0.5	0.0	0.6	0.1	0.4	0.0	0.1	0.4	1.4	0.3	0.2	0.3	0.1	0.0	4.3	6.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.3	0.2	0.3	4.6	0.0	0.7	0.1	1.7	0.2	0.0	1.6	0.1	0.1	118.8	0.0	0.1	0.3	0.1	0.1	0.0	1.1	0.2	0.1	11.3	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.4	0.3	0.3	0.2	0.3	0.2	1.7	0.2
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 472.2"	"Cell line enhanced"	"Detected in some"		"A-431: 14.5;BJ hTERT+ SV40 Large T+: 5.4;HaCaT: 11.5;RPTEC TERT1: 12.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles				Vesicles	Vesicles	"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	2.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.2	2.7	0.0	0.1	47.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.3	472.2	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.2	1.1	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	5.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	5.4	3.5	0.2	4.5	0.0	0.6	0.1	11.5	0.0	3.9	3.6	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.6	1.7	3.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.8	0.7	0.0	0.0	0.0	3.7	0.0	1.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0
KLHL34	"FLJ34960, RP11-450P7.3"	ENSG00000185915	"Kelch like family member 34"	Q8N239	X	21654690-21658330	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 31.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;PC-3: 1.1;SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA060287	Uncertain									"HPA060287: AB_2684243"	"unprognostic (2.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.29e-1)"	0.3	0.1	0.7	0.1	0.9	0.0	0.0	1.7	0.8	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.0	1.8	0.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	3.1	0.6	0.0	31.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	2.8	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.5	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.0	1.1	1.1	0.1	0.8	0.2	0.0	0.2	1.0	0.5	0.0	0.1	0.0	0.1	0.1	0.8	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.3	3.0	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.7	0.9	1.7	0.8	0.5	0.3	0.2	0.0	0.2	0.0
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261825	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"skeletal muscle: 104.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"NK-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"NK-cells: 3.0"	"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	3.0	1.6	4.5	2.1	4.5	1.0	1.8	9.0	7.0	2.1	1.4	2.1	1.6	2.0	5.4	5.1	3.3	2.9	2.4	5.1	3.9	3.6	2.5	1.0	2.1	2.0	3.5	5.7	3.0	1.4	1.2	7.0	2.3	2.6	2.9	1.1	2.2	1.4	3.7	104.2	0.9	1.5	4.2	2.6	1.6	1.5	1.6	2.4	0.0	1.3	10.8	1.1	2.4	1.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	10.3	6.4	2.4	7.4	5.6	6.2	3.5	7.9	6.9	13.3	8.5	9.2	3.2	19.4	10.8	8.7	6.9	11.0	1.6	2.5	5.6	15.4	12.7	19.3	11.4	17.9	11.9	25.2	13.4	2.9	3.0	0.0	15.0	11.2	18.1	6.1	5.7	0.0	15.9	7.5	10.4	18.1	6.7	19.7	7.9	1.4	8.5	2.9	6.1	0.2	9.8	3.3	13.8	7.8	13.7	12.4	2.9	4.9	4.2	3.2	10.4	3.5	11.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	4.5	4.5	9.0	7.0	3.9	3.6	3.5	5.7	2.6	2.4
MYF6	"bHLHc4, MRF4"	ENSG00000111046	"Myogenic factor 6"	P23409	12	80707498-80709474	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 175.1"	"Cell line enriched"	"Detected in some"	17	"LHCN-M2: 22.6"	"Group enriched"	"Detected in some"	11	"head and neck cancer: 3.0;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (2.20e-2)"	"prognostic unfavourable (2.05e-4)"		"unprognostic (9.88e-2)"							"unprognostic (6.64e-1)"			3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	17.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;RH-30: 13.2;RPMI-8226: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA059704: AB_2684108, HPA059890: AB_2684153"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favourable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.0	0.2	5.2	0.1	0.8	0.7	0.4	0.6	0.4	0.7	13.2	10.7	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	2.6	0.2	1.0	0.6	2.9	0.1	0.9	0.2	0.2	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107355	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"skeletal muscle: 399.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdTCR: 37.0;MAIT T-cell: 32.5;memory B-cell: 32.2;memory CD4 T-cell: 38.4;memory CD8 T-cell: 36.9;naive B-cell: 34.1;naive CD4 T-cell: 36.2;naive CD8 T-cell: 34.4;NK-cell: 31.2;T-reg: 45.0"	"Group enriched"	"Detected in many"	9	"B-cells: 34.1;NK-cells: 31.2;T-cells: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol		1200000	1200000	Cytosol	Cytosol	"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	9.5	12.1	21.0	6.7	26.8	3.7	4.2	10.3	24.9	6.2	5.4	36.2	3.6	5.3	5.6	7.3	8.8	7.8	6.4	3.1	24.8	15.2	10.3	4.9	4.6	9.3	26.8	15.8	6.8	5.3	7.3	4.9	6.5	17.3	9.2	4.4	7.9	4.9	7.2	399.9	2.7	5.0	11.6	22.1	10.4	6.1	3.1	26.8	0.0	4.7	30.8	7.3	9.0	7.9	34.1	4.0	1.1	0.6	31.2	45.0	22.4	15.3	8.4	10.1	12.0	30.4	24.4	3.5	4.6	10.1	11.1	7.3	32.2	9.5	0.0	14.3	8.7	2.0	4.5	7.6	3.0	1.7	1.2	4.5	13.8	2.1	27.4	0.0	0.9	22.2	1.9	24.0	4.4	15.0	0.9	0.5	13.7	0.3	1.4	12.8	7.6	9.6	3.5	11.2	1.4	39.3	0.0	6.6	18.8	16.8	6.5	5.1	0.4	2.9	17.9	12.8	12.6	16.3	15.5	0.4	0.4	0.0	18.9	0.8	5.8	0.1	0.6	0.1	37.0	0.3	32.5	32.2	38.4	36.9	2.8	34.1	36.2	34.4	1.1	31.2	0.5	4.0	45.0	22.4	21.0	26.8	10.3	24.9	24.8	15.2	26.8	15.8	17.3	26.8
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell line enriched"	"Detected in single"	72	"RH-30: 42.8"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA7	"HAK6, Kv1.7"	ENSG00000104848	"Potassium voltage-gated channel subfamily A member 7"	Q96RP8	19	49067418-49072941	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 40.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;U-251 MG: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.00e-1)"	"unprognostic (2.10e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.68e-1)"		"unprognostic (4.31e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.70e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.29e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	40.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.6	0.3	0.0	0.0	1.1	0.9	3.3	0.8	0.9	0.8	0.2	0.7	0.3	0.4	2.0	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.5	0.9	0.4	0.2	0.2	1.3	0.1	0.2	0.0	0.4	0.6	0.2	1.4	0.4	0.1	0.6	3.9	0.1	0.3	0.1	0.1	0.0	0.5	1.1	0.1	0.5	0.3	0.6	0.5	0.3	0.4	0.1	0.4	0.2	0.5	0.4	0.4	1.5	0.2	0.1	0.5	1.1	0.7	1.4	0.5	0.9	3.9	0.7	0.3	0.3	0.6	0.4	0.5	3.3	0.8	0.7	0.8	0.4	0.5	0.5	0.7	0.7	0.2	1.1	0.7	0.8	2.6	0.9	0.7	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUSTN1	Mustang	ENSG00000272573	"Musculoskeletal, embryonic nuclear protein 1"	Q8IVN3	3	52833114-52835219	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"skeletal muscle: 252.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 9.4;HSkMC: 5.9;RH-30: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"																				"unprognostic (2.79e-2)"	"unprognostic (3.73e-2)"			"unprognostic (4.11e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.88e-2)"	12.1	1.8	2.5	1.8	5.2	1.3	6.1	1.5	5.7	16.0	4.6	2.6	2.4	1.7	11.1	18.9	7.9	6.4	10.6	15.5	2.6	2.2	1.8	0.8	3.2	1.4	4.3	3.9	5.1	1.6	0.8	1.1	1.3	5.2	11.6	3.4	3.8	5.9	8.9	252.5	2.7	2.6	6.1	2.2	0.9	2.3	6.4	0.2	0.0	5.4	26.9	3.6	8.1	7.9	0.0	0.0	2.1	0.6	0.0	0.3	0.2	0.1	0.2	2.9	0.0	0.8	2.0	3.4	0.2	0.9	0.4	0.3	0.4	0.4	0.0	0.0	1.4	1.2	0.7	0.5	0.4	0.1	0.9	0.0	1.5	9.4	1.4	1.9	0.6	5.9	1.0	0.9	0.0	1.2	0.2	0.0	0.1	0.6	0.7	2.7	0.4	2.1	1.0	8.3	0.0	0.6	0.0	0.3	0.3	0.6	0.7	1.4	0.0	0.7	0.0	0.3	0.7	1.2	0.6	0.0	0.0	0.0	0.3	2.4	0.3	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.6	0.0	0.0	0.2	2.5	5.2	1.5	5.7	2.6	2.2	4.3	3.9	5.2	0.2
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 53.7"	"Group enriched"	"Detected in some"	11	"REH: 9.8;RH-30: 30.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"				Nucleoplasm	Nucleoplasm	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	5.9	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.3	0.3	0.0		0.1	0.0		0.5	0.0	53.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4			1.6		0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	9.8	30.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0										
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 212.4"	"Cell line enriched"	"Detected in single"	32	"U-266/70: 13.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"memory B-cell: 3.0"	"Lineage enriched"	"Detected in single"	31	"B-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"					"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	2.9	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.2	3.3	0.0	0.0	3.5	0.1	3.3	1.4	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.6	1.2	0.0	2.1	1.5	212.4	0.1	1.4	0.0	0.1	0.5	0.7	0.1	0.0	0.0	0.2	25.3	2.8	0.2	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112566	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 83.1"	"Group enriched"	"Detected in some"	32	"BEWO: 5.4;HSkMC: 6.9"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	20	"olfactory region: 5.3"	"CAB009507, HPA048892, HPA056815"	Enhanced									"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: "	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.0
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 96.7"	"Group enriched"	"Detected in some"	18	"LHCN-M2: 87.3;RH-30: 71.4"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Cell type enriched"	"Detected in single"	27	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA071554	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	4.5	0.0	0.5	0.5	0.1	0.0	0.6	0.0	0.4	0.7	1.7	0.0	0.1	0.2	0.0	4.6	1.2	0.0	0.0	0.3	2.0	0.1	0.0	0.2	0.7	0.9	0.1	0.0	0.0	0.0	0.0	12.1	0.2	0.0	2.4	1.0	0.0	1.5	0.0	96.7	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.5	0.0	4.5	1.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	87.3	0.0	0.0	0.0	0.0	0.0	0.0	71.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.1	0.0	0.4	2.0	0.1	0.1	0.0	0.0	0.0
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell line enhanced"	"Detected in many"		"BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006135	Enhanced		Supported	"Plasma membrane,Cytosol"		54000000	54000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA006135: AB_1848602"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.1	8.6	0.8	78.6	14.9	22.4	10.8	24.4	0.2	0.0	13.3	35.8	0.0	4.8	0.1	13.3	0.0	2.6	0.0	4.0	0.0	9.0	0.0	0.0	16.3	0.0	38.9	0.0	13.9	9.4	0.0	15.2	0.0	0.0	0.3	13.1	4.5	0.0	26.0	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	0.1	0.3	28.8	7.8	33.6	2.0	0.0	0.0	0.0	0.0	26.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6
NEB	"NEB177D, NEM2"	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 505.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.7;RH-30: 26.6;U-266/70: 10.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 7.4;olfactory region: 4.9"	"Region enriched"	"Detected in some"	7	"cerebellum: 25.3"	HPA016601	Enhanced									"HPA016601: AB_1854361"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-13)"	"unprognostic (6.80e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.06e-2)"	9.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	5.2	4.0	0.0	0.8	1.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	3.8	0.0	505.8	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	3.0	65.9	2.6	0.1	0.0	1.3	0.5	1.7	0.6	0.8	0.9	0.3	0.3	0.3	0.6	0.5	0.1	0.1	1.7	0.3	0.0	0.0	0.0	4.6	0.5	1.2	0.9	0.1	0.9	0.1	0.0	0.0	0.6	0.7	0.4	0.6	1.5	0.0	0.8	1.1	4.0	0.2	0.0	0.0	0.6	0.9	6.7	0.4	0.5	0.4	0.7	1.1	0.8	1.1	26.6	0.1	0.0	0.9	1.5	0.2	0.2	0.3	0.1	0.7	0.8	0.6	0.7	0.9	0.1	0.9	10.0	1.4	0.3	0.1	0.6	1.1	1.2	0.6	1.7	0.9	0.0	0.9	1.2	0.8	0.5	0.0	1.3	0.3	0.4	1.1	0.8	0.0	0.5	0.4	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"									HPA043010	Uncertain		Uncertain	"Vesicles,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.0	1.2	2.9	0.2	0.4	2.2	6.4	6.5	7.6	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	0.8	0.6	8.1	0.7	2.1	0.0	1.1	0.0	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	0.2	1.5	1.0	16.5	14.1	1.3	0.5	2.7	1.8	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8										
TMEM233	IFITMD2	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593459-119643066	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 88.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.3;RH-30: 6.0;U-2197: 9.0;U-87 MG: 36.2"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047506: , HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.6	0.3	0.8	0.0	0.4	0.0	0.6	0.1	8.8	0.2	0.2	0.0	0.0	0.1	0.9	0.6	0.2	0.2	1.0	0.7	0.2	0.5	0.5	0.3	0.6	0.2	0.1	1.4	0.6	0.1	1.7	0.4	0.0	0.4	0.4	0.1	0.7	0.5	0.3	88.0	0.1	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.1	11.1	5.2	0.3	0.4	1.8	0.3	0.3	0.7	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	11.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.5	0.7	0.6	0.1	0.3	0.1	0.1	0.8	0.4	0.1	1.5	0.2	0.5	0.1	1.4	0.4	0.0
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132794-55149354	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 1047.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 119.1;RH-30: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 53.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 53.3"	"Region enriched"	"Detected in many"	5	"thalamus: 136.6"	"Low region specificity"	"Detected in many"			"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus, Cytosol"	"Nucleoplasm, Golgi apparatus, Cytosol"	"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavourable (4.66e-4)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	3.2	0.0	1.6	0.0	1.0	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.1	0.0	24.4	22.3	0.4	0.1	6.1	0.9	0.4	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	7.2	0.0	0.0	11.5	0.0	1047.7	1.8	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	9.2	124.4	17.8	0.3	0.1	0.1	9.9	53.3	11.6	0.1	0.1	2.6	24.3	14.3	0.1	3.1	0.0	0.2	4.7	1.1	4.2	1.6	4.7	5.2	16.2	0.3	9.5	0.4	12.4	3.4	10.6	1.3	1.6	27.0	4.6	1.5	0.9	0.5	0.3	119.1	5.3	17.2	0.4	18.3	0.0	23.1	22.6	1.5	23.2	0.4	0.0	3.0	28.4	15.5	89.7	2.9	3.7	0.8	0.9	7.0	1.5	0.2	7.8	14.8	14.2	0.5	23.6	35.1	0.9	1.7	0.1	0.9	1.1	24.8	3.6	7.1	0.5	11.6	53.3	0.0	5.9	0.1	0.0	0.1	0.0	9.9	0.1	0.1	0.1	0.5	0.1	2.6	0.2	0.0	2.6	1.6	1.0	0.1	1.0	0.9	0.4	0.5	0.0	0.0	0.0
VGLL2		ENSG00000170162	"Vestigial like family member 2"	Q8N8G2	6	117265558-117273565	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 75.9"	"Group enriched"	"Detected in some"	6	"RH-30: 17.1;U-2 OS: 6.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.4"	"Low region specificity"	"Detected in many"																		"unprognostic (3.02e-2)"	"unprognostic (3.09e-2)"				"unprognostic (1.75e-1)"					"unprognostic (4.92e-1)"			0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	9.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	1.7	0.3	75.9	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.0	7.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	2.0	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.3	0.0
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851396-11854449	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 250.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"	"Nucleoplasm, Midbody"	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favourable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	16.0	13.6	14.9	12.5	11.6	19.5	13.3	8.8	16.0	10.1	14.1	10.0	13.8	14.0	10.4	14.7	14.5	9.1	14.6	17.0	11.2	12.3	12.2	11.2	11.3	14.0	11.6	11.9	11.3	11.2	9.7	12.4	11.8	12.1	10.3	14.1	9.4	12.6	29.5	250.9	15.2	20.4	11.6	13.8	11.3	12.8	6.8	10.0	14.2	19.9	19.4	9.9	14.3	10.1	6.7	13.1	34.4	16.5	7.4	9.1	10.6	12.8	12.6	16.4	13.8	21.5	15.1	23.8	13.8	23.3	9.4	12.6	16.3	13.0	8.0	20.7	14.9	11.0	7.4	19.2	8.4	7.4	9.2	5.8	19.2	13.4	15.9	22.1	10.0	21.9	41.6	10.5	24.5	13.6	9.8	10.4	14.8	15.9	15.3	17.0	6.8	6.3	7.9	8.4	13.7	25.2	17.7	16.0	16.0	23.4	11.0	21.1	9.0	20.4	19.8	21.2	11.2	16.7	14.7	12.5	14.3	10.2	19.6	10.3	10.0	10.9	16.5	27.7	7.2	15.3	6.6	6.5	6.7	8.5	13.1	6.7	8.4	7.7	34.4	7.4	15.0	11.7	9.1	10.6	14.9	11.6	8.8	16.0	11.2	12.3	11.6	11.9	12.1	10.0
DWORF		ENSG00000240045	"DWARF open reading frame"		3	155290229-155293775	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 173.0"	"Low cell line specificity"	"Detected in some"			"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Region enriched"	"Detected in some"	8	"basal ganglia: 19.5"																			"unprognostic (6.77e-4)"		"unprognostic (1.60e-2)"					"unprognostic (6.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.33e-2)"				0.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.2	2.9	0.0	0.0	0.6	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	173.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	23.7	0.9	0.0	0.0	0.5	0.4	2.9	0.2	0.4	0.2	0.0	0.2	0.0	0.5	0.0	0.0	2.3	0.7	0.3	0.0	0.0	0.6	0.0	1.3	0.0	0.4	0.0	0.5	0.3	0.5	0.0	0.3	0.6	0.4	0.5	0.5	0.0	1.8	0.4	2.0	0.0	0.0	0.4	0.8	0.6	1.3	1.2	0.4	0.2	1.7	1.1	0.6	0.3	0.2	0.3	0.0	0.0	1.0	0.9	0.0	0.7	0.1	0.9	1.1	1.9	1.7	1.2	0.8	0.2	0.2	0.3	0.8	0.7	0.3	0.0	2.9	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.5	0.2	0.2	0.8	0.4	0.1	0.4	0.1	0.0										
KLHL30	FLJ43374	ENSG00000168427	"Kelch like family member 30"	Q0D2K2	2	238138722-238152947	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 62.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.0;CAPAN-2: 3.1;EFO-21: 3.0;RH-30: 8.6;THP-1: 4.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	35	"olfactory region: 11.6"	"Low region specificity"	"Detected in all"			HPA062095			Approved	"Centriolar satellite"				"Centriolar satellite"	"Centriolar satellite"	"HPA062095: AB_2684680"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.07e-4)"	"unprognostic (6.02e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.17e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.06e-1)"	4.4	0.1	0.1	0.3	0.1	0.1	2.4	0.1	0.1	1.2	0.5	0.1	0.1	0.2	1.2	2.3	1.3	0.4	0.4	6.1	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.7	0.3	1.4	0.1	0.8	1.7	0.6	62.8	0.2	0.3	1.5	0.1	0.1	0.3	0.4	0.0	0.0	0.9	8.7	0.2	1.6	1.4	0.7	1.4	1.1	2.5	0.5	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.0	0.0	0.1	0.1	0.0	0.2	3.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.2	2.1	0.2	0.0	2.6	8.6	1.4	0.6	0.0	0.1	0.2	0.1	0.8	0.2	0.0	4.2	0.0	0.1	0.5	0.2	0.0	0.3	0.3	0.1	0.2	0.5	0.1	0.5	2.5	0.3	0.2	0.5	0.2	0.7	0.1	0.1	1.4	0.6	0.2	0.3	1.1	0.5	0.3	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0
KLHL40	"KBTBD5, NEM8, SRYP"	ENSG00000157119	"Kelch like family member 40"	Q2TBA0	3	42685519-42692544	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 132.0"	"Group enriched"	"Detected in some"	19	"HSkMC: 3.1;RH-30: 3.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024463, HPA052201"	Enhanced									"HPA024463: AB_1852095, HPA052201: AB_2681759"					"unprognostic (1.13e-1)"	"unprognostic (3.28e-2)"			"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"		"unprognostic (7.85e-2)"			"unprognostic (2.50e-1)"	"unprognostic (4.04e-1)"		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	0.0	132.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.7	19.6	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC20	"FLJ10751, FLJ10844"	ENSG00000172731	"Leucine rich repeat containing 20"	Q8TCA0	10	70298970-70382650	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 111.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039630			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA039630: "	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	1.3	2.5	5.6	1.4	7.2	1.6	1.4	5.2	11.2	3.3	3.2	2.5	0.0	1.4	2.7	3.1	7.1	2.4	2.1	15.8	5.0	3.9	1.2	8.3	2.2	1.7	3.7	6.3	2.2	1.3	2.1	3.6	1.1	4.9	2.6	2.0	1.8	1.8	2.4	111.8	1.6	1.4	3.5	2.0	1.4	1.6	3.5	1.9	1.6	2.6	14.3	3.1	2.2	4.8	0.9	2.6	0.0	1.0	1.1	4.1	1.1	14.6	11.3	7.3	15.6	4.1	3.3	0.0	1.9	6.6	5.0	4.7	9.6	15.3	2.9	7.8	1.4	5.3	7.1	10.6	3.5	8.2	2.3	1.7	2.5	22.0	4.5	4.2	1.4	1.3	3.2	6.9	2.3	9.7	2.1	4.7	4.6	2.3	16.0	3.5	2.4	25.7	13.4	4.2	8.3	6.5	1.5	18.5	8.0	1.2	1.3	5.1	1.9	4.3	5.9	4.0	34.6	5.3	4.5	7.6	13.4	4.8	6.5	17.4	0.8	0.0	0.9	0.0	1.7	1.0	1.4	0.9	1.3	1.9	2.6	0.0	4.1	1.5	0.0	1.1	0.7	0.4	0.2	1.1	5.6	7.2	5.2	11.2	5.0	3.9	3.7	6.3	4.9	1.9
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668771-110801620	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"skeletal muscle: 50.0"	"Group enriched"	"Detected in some"	15	"LHCN-M2: 19.3;RH-30: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Not detected"	"Not detected"														"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	7.5	0.3	0.6	5.8	0.7	0.0	0.2	0.1	0.2	0.3	6.8	0.0	0.0	2.3	0.2	4.0	3.8	0.1	2.1	3.2	0.9	0.7	0.2	0.5	4.2	0.9	0.2	0.1	0.3	0.3	0.0	0.2	0.6	0.3	1.9	5.3	0.0	0.4	0.0	50.0	0.3	5.0	3.0	0.3	0.2	2.6	5.9	0.0	0.0	0.3	1.4	3.9	3.6	2.9	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.4	0.2	0.0	19.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.2	0.9	0.7	0.2	0.1	0.3	0.0
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071124-29180412	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 179.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019646	Supported					80000	80000			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	8.3	3.6	11.9	5.8	15.5	7.7	8.6	23.1	18.7	6.1	6.7	15.9	3.6	9.0	6.5	5.4	11.8	4.4	7.2	24.6	15.2	9.4	4.0	9.2	5.2	4.8	13.6	9.9	5.1	9.3	7.4	3.4	4.0	11.4	6.0	4.8	4.4	7.4	5.1	179.7	11.7	9.0	6.3	15.7	4.8	9.0	4.3	12.9	8.0	5.7	14.5	9.1	4.8	5.9	2.2	2.3	2.9	1.8	2.1	3.0	0.7	15.0	21.3	8.2	4.2	2.2	3.8	13.2	7.2	7.2	6.3	4.4	5.3	10.7	1.5	8.1	5.1	17.3	3.2	12.0	2.5	17.5	6.0	1.3	6.3	5.8	3.3	1.8	1.9	4.4	7.1	3.8	1.7	2.3	18.6	2.8	3.1	5.2	5.4	1.5	1.7	4.7	19.0	9.2	4.7	4.9	11.2	4.3	4.4	7.1	24.1	5.3	5.6	2.2	2.6	4.1	5.1	2.8	4.9	5.3	8.9	3.0	5.2	1.3	11.0	2.5	1.6	2.4	2.3	1.8	3.0	0.9	1.7	1.8	1.8	2.2	2.4	1.4	2.9	2.1	1.7	2.3	1.3	0.7	11.9	15.5	23.1	18.7	15.2	9.4	13.6	9.9	11.4	12.9
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719568-17722131	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 31.8"	"Cell line enriched"	"Detected in some"	15	"RH-30: 101.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 0.5"	"HPA055436, HPA078647"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	4.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	101.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 559.6"	"Cell line enriched"	"Detected in some"	9	"RH-30: 103.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli		25000	25000	Nucleoplasm	Nucleoplasm	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.9	9.5	0.0	0.1	6.6	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.8	0.0	559.6	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.7	83.8	10.7	0.0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	103.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051304-26068436	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 271.4"	"Group enriched"	"Detected in some"	38	"ASC diff: 10.5;SK-MEL-30: 33.5"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	1.7	0.0	0.6	38.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.0	3.6	1.0	0.0	271.4	0.6	0.1	0.9	0.1	0.0	0.1	0.1	0.0	0.0	1.7	12.7	0.8	1.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723312	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 612.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol		56000	56000	Cytosol	Cytosol	"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	23.8	5.0	3.0	6.4	6.0	11.2	15.9	2.1	4.6	12.4	14.3	2.0	3.7	3.2	8.5	14.7	25.0	8.4	6.7	91.6	3.2	1.7	7.6	6.5	17.2	6.8	5.5	0.8	17.2	20.6	1.3	8.1	9.5	6.2	12.4	5.3	6.2	12.9	6.8	612.6	29.9	5.0	14.9	5.8	8.6	9.5	30.2	4.1	4.5	18.5	54.2	12.0	27.2	24.6	9.5	4.5	1.0	5.7	0.9	2.3	1.4	17.7	15.6	7.0	22.8	29.2	54.2	51.2	27.8	23.7	23.8	22.4	27.3	43.1	17.4	9.3	22.1	34.1	29.9	57.9	20.7	0.1	53.7	14.4	22.0	16.6	36.5	25.9	1.6	62.5	75.2	22.1	72.7	54.7	19.4	0.0	25.5	19.0	21.3	22.3	70.6	12.8	12.0	32.0	19.7	32.3	23.6	8.7	0.0	21.1	21.0	25.8	6.0	20.4	35.7	16.3	45.9	17.4	31.2	0.1	5.7	2.0	22.5	0.0	17.5	0.0	5.7	0.0	0.7	5.4	0.0	1.6	0.0	2.1	4.5	9.5	0.1	2.3	1.0	0.9	3.0	0.2	0.1	1.4	3.0	6.0	2.1	4.6	3.2	1.7	5.5	0.8	6.2	4.1
AC083902.2		ENSG00000248713	"Homo sapiens uncharacterized LOC285556 (LOC285556), mRNA."		4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 40.9"	"Cell line enhanced"	"Detected in some"		"RH-30: 5.4;SK-BR-3: 3.5;SK-MEL-30: 2.0;WM-115: 1.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"														"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.2	0.0	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	40.9	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.1	0.7	6.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Supported	Cytosol		1200000000	1200000000	Cytosol	Cytosol	"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavourable (5.79e-5)"	"prognostic unfavourable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.7	104.6	31.5	101.2	48.3	55.1	100.7	84.0	87.6	85.7	107.2	73.9	107.0	94.6	137.8	84.8	106.0	63.1	183.2	62.9	41.6	83.0	77.4	83.9	163.2	75.4	112.5	83.1	75.5	64.7	96.2	64.7	63.1	66.6	62.5	90.8	197.9	68.4	93.0	78.3	88.2	102.1	50.6	211.5	106.7	79.0	63.1	44.4	52.4	221.1	78.4	94.0	76.3	75.0	126.6	50.5	69.0	90.8	123.5	84.3	86.6	235.6	109.3	99.9	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9
BEST3	"MGC13168, MGC40411, VMD2L3"	ENSG00000127325	"Bestrophin 3"	Q8N1M1	12	69643360-69699476	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 125.0"	"Group enriched"	"Detected in some"	16	"REH: 18.3;RPMI-8226: 19.6;U-698: 32.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054582	Approved									"HPA054582: AB_2682530"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.26e-3)"		"unprognostic (7.30e-7)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.47e-2)"		"unprognostic (3.03e-1)"	1.6	0.5	1.7	0.1	1.9	2.4	0.6	6.3	9.3	0.2	0.2	0.9	0.0	0.2	0.2	2.4	1.7	0.1	0.2	0.4	1.8	0.7	0.4	0.3	0.1	0.2	1.8	0.6	0.2	1.0	0.1	0.7	0.3	1.2	1.7	0.2	0.1	1.9	0.1	125.0	0.9	0.1	0.1	1.9	0.1	0.1	2.5	1.0	0.5	0.2	21.9	0.7	0.1	0.0	1.2	0.9	1.7	0.5	0.6	1.0	0.7	0.1	0.2	0.7	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.4	0.1	0.2	1.3	0.3	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.2	0.2	0.0	0.8	0.1	0.0	0.0	0.7	0.3	18.3	0.6	19.6	0.9	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	32.7	1.4	0.0	0.1	0.3	0.5	0.3	0.5	0.4	0.8	1.2	1.0	0.7	0.3	0.8	1.0	1.0	1.7	0.6	0.4	0.9	0.4	0.7	1.7	1.9	6.3	1.5	1.8	0.7	1.8	0.6	1.2	1.0
CACNB1	CACNLB1	ENSG00000067191	"Calcium voltage-gated channel auxiliary subunit beta 1"	Q02641	17	39173456-39197703	"FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 130.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023343	Approved									"HPA023343: AB_1845866"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (3.99e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-11)"	"unprognostic (7.62e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.44e-3)"	2.0	2.4	7.8	2.2	14.9	1.6	2.0	5.4	22.0	3.3	2.3	2.0	6.0	1.7	2.3	3.7	4.2	2.3	2.0	2.8	8.6	6.4	1.3	1.1	3.0	2.1	3.3	11.0	2.6	1.4	1.6	2.0	1.8	7.6	3.6	2.2	0.8	3.4	5.7	130.9	5.8	1.7	2.4	1.9	2.0	1.8	2.3	2.1	1.7	2.0	7.3	1.8	1.8	1.6	0.1	3.1	0.1	1.2	1.8	3.2	0.8	6.0	2.7	3.4	7.8	3.8	4.7	0.1	3.6	4.5	3.4	4.3	2.0	6.1	10.4	3.8	5.4	5.6	3.3	6.0	2.6	4.9	3.7	1.4	6.4	0.8	7.8	0.3	0.9	5.1	1.9	7.1	8.1	2.4	0.9	9.1	3.5	1.6	7.4	2.7	2.4	2.0	5.1	11.3	4.5	1.4	1.9	8.5	5.2	2.1	11.5	3.4	8.1	4.1	3.4	6.1	7.1	4.5	3.6	4.3	1.4	1.7	5.1	0.0	2.5	0.0	1.2	0.0	2.0	0.6	3.2	0.1	1.9	2.6	0.5	0.1	0.6	1.2	0.1	1.8	0.3	3.1	0.5	0.8	7.8	14.9	5.4	22.0	8.6	6.4	3.3	11.0	7.6	2.1
DDIT4L	"REDD2, Rtp801L"	ENSG00000145358	"DNA damage inducible transcript 4 like"	Q96D03	4	100185870-100190782	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 106.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 13.8;BJ: 20.2;fHDF/TERT166: 10.9;HSkMC: 10.5;RPTEC TERT1: 14.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050903			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane"	"Plasma membrane"	"HPA050903: "	"unprognostic (2.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (5.77e-4)"	"unprognostic (1.66e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.53e-5)"	"unprognostic (4.99e-3)"	1.4	0.5	1.5	0.3	6.3	0.3	0.6	2.0	1.6	7.9	0.6	1.7	0.0	0.2	0.9	3.0	2.6	0.9	0.3	3.5	2.1	0.7	6.2	0.2	0.4	0.3	1.5	1.6	2.8	0.2	0.3	1.2	1.3	2.7	3.8	0.5	5.2	6.3	2.6	106.4	0.4	0.3	0.8	2.4	0.5	0.2	1.1	1.7	0.0	0.6	18.6	1.2	0.5	0.9	0.2	0.0	0.0	0.2	0.0	2.0	0.2	0.0	1.5	5.9	0.0	2.7	13.8	0.8	20.2	1.7	0.3	0.1	0.1	0.6	0.0	0.5	10.9	0.0	4.2	0.3	0.4	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	10.5	0.1	0.2	1.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	6.7	0.0	0.4	0.0	0.0	14.4	0.0	0.0	0.0	0.4	0.8	2.7	0.0	0.1	0.1	0.0	0.0	0.0	1.5	2.7	0.0	0.0	5.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	1.0	0.2	1.5	6.3	2.0	1.6	2.1	0.7	1.5	1.6	2.7	1.7
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.3;HBF TERT88: 27.8;MCF7: 45.7;SCLC-21H: 29.1;T-47d: 23.7;U-2 OS: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Supported	Cytosol		55000000	55000000	Cytosol	Cytosol	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: , HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.6	0.2	2.5	0.0	0.1	1.3	2.1	0.3	10.5	3.5	1.4	7.0	0.0	18.6	0.1	5.0	55.3	0.1	27.8	0.1	2.5	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.1	45.7	0.1	0.1	1.9	17.8	1.3	0.0	1.7	0.4	0.5	29.1	17.7	16.8	1.9	0.1	23.7	0.6	0.0	0.0	32.4	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6
FEM1A		ENSG00000141965	"Fem-1 homolog A"	Q9BSK4	19	4791681-4801273	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 103.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016565, HPA063622"			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA016565: , HPA063622: AB_2685063"	"unprognostic (4.62e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (6.18e-5)"	"unprognostic (3.72e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.70e-2)"	3.0	2.4	3.3	2.2	4.4	3.3	4.0	4.1	5.0	2.0	2.7	3.0	0.9	2.2	2.7	4.0	4.2	2.1	1.9	8.6	3.3	2.6	2.2	4.4	2.3	3.8	3.2	2.5	2.1	4.2	4.4	2.3	4.5	3.1	2.8	2.0	2.7	3.1	2.1	103.9	6.9	2.3	2.3	2.2	2.7	2.2	2.2	3.2	4.2	2.1	18.6	3.0	2.5	2.3	7.2	6.8	9.1	8.2	6.8	6.9	4.2	7.2	5.0	4.7	10.2	5.3	3.1	6.8	4.3	3.6	7.0	4.9	7.8	3.4	8.2	4.5	5.4	7.5	8.2	7.2	4.6	9.7	9.4	8.0	4.0	5.8	7.9	13.2	10.3	4.5	11.1	5.4	7.8	5.0	11.7	15.8	4.8	7.3	11.0	4.9	14.5	12.2	10.3	6.1	8.7	6.3	9.3	15.3	10.9	5.7	10.8	8.1	8.3	11.5	7.0	6.5	4.6	10.0	11.4	18.4	15.2	7.1	6.6	9.6	9.0	9.1	7.3	7.1	6.9	8.2	6.0	5.3	5.5	6.3	6.8	7.2	5.0	5.7	6.6	6.8	7.3	6.6	3.9	4.2	3.3	4.4	4.1	5.0	3.3	2.6	3.2	2.5	3.1	3.2
FGF8	AIGF	ENSG00000107831	"Fibroblast growth factor 8"	P55075	10	101770130-101780369	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 30.5"	"Cell line enriched"	"Detected in some"	20	"RH-30: 30.6"	"Group enriched"	"Detected in some"	8	"endometrial cancer: 2.1;testis cancer: 3.3;urothelial cancer: 0.7"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in other tissues"						"unprognostic (1.56e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.09e-2)"		"unprognostic (8.75e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.35e-9)"	"unprognostic (6.17e-3)"	"unprognostic (9.01e-2)"		"unprognostic (1.97e-1)"	0.3	0.0	0.6	0.1	0.6	0.0	0.2	0.1	2.2	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	1.9	1.9	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	30.5	0.0	0.1	0.1	0.2	0.3	0.0	3.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	2.1	1.6	4.8	3.0	2.6	2.5	1.3	0.4	0.1	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.5	0.0	0.4	0.2	0.0	0.0	0.7	0.7	0.2	0.1	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.3	0.4	1.5	0.1	0.0	0.4	30.6	0.6	0.0	0.2	0.6	0.6	0.0	0.4	0.3	0.5	0.0	0.4	0.5	0.9	0.6	0.1	0.1	0.5	0.9	0.6	0.5	0.6	4.8	1.5	1.8	1.2	1.9	2.5	1.6	1.9	1.5	1.4	2.1	2.4	2.3	4.2	2.6	3.0	1.6	1.7	1.3	0.6	0.6	0.1	2.2	1.9	1.9	0.3	0.1	0.1	0.1
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	37.8	17.6	38.1	29.6	29.3	33.5	17.2	30.1	30.8	33.9	33.6	25.9	19.1	19.3	49.9	20.7	18.3	30.7	18.5	47.5	25.5	20.7	19.7	23.3	29.5	31.3	12.2	16.3	35.3	21.2	17.1	41.0	34.1	15.7	23.5	42.6	13.7	23.2	20.5	43.0	19.4	16.1	48.7	20.6	26.1	11.9	16.1	20.6	26.1	30.4	38.9	42.2	23.5	27.2	25.6	28.6	16.0	59.2	22.0	27.5	23.0	26.7	17.6	32.5	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 21.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.5	0.3	0.2	0.2	0.3	1.0	0.4	0.5	0.7	0.4	0.2	0.0	0.0	0.1	0.2	1.6	1.4	0.2	2.0	2.3	0.2	0.3	0.7	0.2	1.6	0.3	0.3	0.8	0.5	0.3	0.1	0.6	0.5	2.1	0.5	0.1	0.3	0.3	0.0	21.6	0.8	0.2	2.5	0.7	0.5	0.2	1.1	0.0	0.0	1.2	3.3	0.7	0.5	0.3	1.7	0.5	1.9	0.8	0.5	1.3	0.3	1.3	0.3	0.8	1.1	0.9	0.5	1.5	0.6	0.3	0.3	0.2	1.3	1.2	1.1	0.5	0.2	0.9	9.7	0.3	0.4	1.7	0.5	1.6	1.5	0.5	0.4	0.9	3.3	0.4	0.5	0.7	0.3	0.6	1.2	4.0	0.9	1.1	0.6	1.3	1.8	0.5	1.9	2.1	1.0	1.0	1.5	1.1	0.9	1.1	0.7	2.9	1.1	0.8	5.0	1.5	1.4	1.9	0.7	1.6	0.8	0.7	0.6	0.9	1.9	1.9	0.7	0.8	1.0	0.6	0.8	1.2	0.9	0.6	0.4	1.7	1.1	1.0	1.7	0.5	0.8	0.5	1.3	0.3	0.2	0.3	0.5	0.7	0.2	0.3	0.3	0.8	2.1	0.0
KIAA1024L		ENSG00000186367	"KIAA1024 like"	P59773	5	129748079-129766732	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 26.0"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA013760	Uncertain									"HPA013760: AB_1852363"				"unprognostic (1.77e-1)"										"unprognostic (5.13e-1)"				0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.0	2.8	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.1	2.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	26.0	0.0	0.0	0.0	0.3	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	2.8	4.1	1.1	0.8	0.8	0.1	0.6	0.1	0.1	1.9	0.2	0.1	0.5	0.3	0.2	0.3	0.4	0.1	3.1	1.0	1.3	0.2	1.6	0.0	0.3	0.2	1.6	1.2	0.4	0.7	0.8	0.0	0.2	1.4	0.6	0.4	0.1	0.4	0.2	0.4	2.1	0.5	0.4	1.5	1.7	1.2	1.6	0.3	0.5	0.6	0.5	0.8	0.8	4.7	0.2	3.1	0.5	1.2	0.3	0.2	1.6	1.2	0.9	0.3	0.2	0.8	0.5	1.2	0.1	2.4	4.1	1.1	0.6	0.8	0.6	0.8	0.6	0.6	0.5	0.3	1.6	0.6	0.8	2.6	0.8	1.0	2.8	0.3	0.1	0.1	0.9	0.0	2.8	0.1	2.0	0.3	0.0	1.9	0.0
MIB2	"FLJ39787, skeletrophin, ZZANK1, ZZZ5"	ENSG00000197530	"Mindbomb E3 ubiquitin protein ligase 2"	Q96AX9	1	1615415-1630610	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 72.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.1;SCLC-21H: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068322	Enhanced									"HPA068322: AB_2685973"	"unprognostic (3.93e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.01e-2)"	6.4	3.9	8.7	6.4	10.0	4.5	4.7	8.8	11.5	4.8	6.9	7.1	4.7	5.3	5.1	5.4	11.4	4.1	3.7	6.1	9.1	7.9	5.5	6.2	5.1	3.7	5.3	7.1	5.8	7.0	3.7	9.4	4.0	5.7	4.7	3.7	6.6	5.4	6.5	72.5	9.6	4.6	5.4	3.4	9.0	8.5	5.2	5.8	7.4	5.9	9.7	4.1	4.5	4.1	2.9	9.2	1.9	0.1	7.3	4.7	1.0	6.5	0.9	0.4	1.5	1.7	0.6	9.1	3.1	1.4	1.0	2.3	1.3	1.6	0.7	4.4	0.9	13.1	0.5	2.0	0.0	3.4	5.6	0.5	1.9	1.2	2.4	0.8	2.2	1.4	1.4	0.6	0.2	0.5	2.6	1.2	0.2	1.0	3.6	8.3	1.1	10.4	6.1	1.9	8.9	0.1	0.8	14.0	5.1	5.2	0.7	5.0	1.0	3.2	0.6	0.9	2.1	5.1	0.9	6.8	2.0	1.8	2.3	2.6	1.1	0.0	0.1	1.9	4.3	0.1	4.3	2.6	3.3	4.7	0.0	2.9	3.9	2.9	0.5	7.3	0.0	9.2	2.3	1.0	8.7	10.0	8.8	11.5	9.1	7.9	5.3	7.1	5.7	5.8
PKIA	PRKACN1	ENSG00000171033	"CAMP-dependent protein kinase inhibitor alpha"	P61925	8	78516139-78605267	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 258.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.3;HUVEC TERT2: 37.5;RT4: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.5"	"Lineage enriched"	"Detected in many"	9	"T-cells: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042791	Uncertain									"HPA042791: AB_10795761"	"unprognostic (3.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.59e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.65e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavourable (5.41e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.52e-3)"	1.6	3.5	17.8	2.4	28.9	1.7	2.1	17.2	18.2	1.6	1.7	4.6	0.0	1.4	1.8	3.1	6.4	2.5	3.1	46.4	13.7	14.9	2.3	1.1	3.2	2.8	8.9	15.8	2.6	1.4	21.2	3.7	1.5	6.7	6.1	1.8	0.7	2.2	2.5	258.0	3.3	1.5	1.7	6.0	2.0	1.5	1.3	6.7	6.2	9.7	46.1	3.7	3.5	1.2	1.9	0.1	0.3	0.1	1.3	16.5	2.1	0.2	0.1	12.5	0.0	6.9	1.8	0.0	11.5	2.2	1.2	2.6	0.0	1.9	5.2	0.0	1.7	0.1	4.0	3.6	8.2	22.3	8.9	6.4	1.4	0.0	0.4	0.0	3.8	2.8	0.5	0.0	3.5	37.5	0.0	5.7	18.6	1.9	9.7	0.0	2.9	12.8	0.0	10.7	0.0	6.8	35.7	6.1	11.9	1.5	9.6	0.0	0.0	0.0	14.7	2.9	2.4	0.6	6.8	2.3	2.3	1.7	13.6	0.0	3.5	0.0	0.0	0.0	0.4	0.0	0.3	1.9	7.7	1.5	0.0	1.8	6.8	3.9	0.3	1.3	0.1	0.1	16.5	2.1	17.8	28.9	17.2	15.5	13.7	14.9	8.9	15.8	6.7	6.7
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395713	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 37.7"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 47.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.1;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060103	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favourable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	0.6	1.6	0.7	0.3	0.8	0.0	0.3	0.0	0.3	0.3	0.3			0.6	0.5	0.1	0.3	0.7	0.1	6.6	0.7	0.6	0.7	0.0	0.0	0.4	0.5		0.0	0.0	1.8	0.8	0.2		1.3	0.0		0.7	0.6	37.7	0.0	0.8	0.1	0.2	0.3	0.6	0.0			0.1		0.1	0.3	0.1	0.5	1.1	0.0	0.1	0.0	1.1	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.2	0.5	0.1	0.5	0.5	1.9	1.2	2.9	0.5	1.5	0.3	0.2	0.0	0.1	47.0	0.6	0.7	1.1	0.2	1.3	0.0	1.6	0.4	0.4	1.1	0.3	0.0	0.2	3.0	1.6	0.5	2.4	1.2	0.6	1.2	7.5	0.2	5.6	0.1	0.0	0.6	0.3	2.8	2.9	0.1	1.1	1.6	0.2	0.0	0.1	0.1	0.2	0.4	0.8	4.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	1.1	1.1	0.0										
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 225.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Enhanced	Nucleoplasm,Cytosol		3100000	3100000	Nucleoplasm	Nucleoplasm	"HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: "	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	19.6	15.2	19.1	13.4	17.7	19.9	16.0	15.1	25.3	12.9	18.0	14.6	10.7	13.6	15.3	14.3	19.9	17.7	13.6	34.3	16.6	16.0	13.2	24.5	14.2	14.1	15.4	15.6	17.1	21.1	14.0	12.3	17.3	15.5	15.1	10.7	12.6	18.6	15.8	225.3	19.8	11.9	16.5	15.4	15.7	14.9	19.1	12.5	14.6	17.2	37.7	13.8	20.7	17.0	29.5	30.0	22.7	35.6	26.5	32.1	22.5	31.4	11.6	13.5	13.9	22.5	25.8	22.6	15.4	31.0	36.6	33.3	13.0	22.7	26.8	35.5	23.1	24.4	18.4	32.0	13.9	37.8	23.4	10.8	15.0	12.5	43.8	23.3	31.7	26.3	48.0	26.4	50.6	25.1	27.7	24.7	32.9	30.7	29.0	28.9	18.5	28.8	15.3	14.0	43.5	28.5	12.6	25.0	19.7	17.0	31.1	34.0	24.2	40.5	19.7	52.7	14.0	62.5	47.0	35.8	29.9	19.5	43.4	44.1	43.2	10.4	27.9	22.7	29.7	35.6	32.1	29.2	25.3	25.1	23.4	29.5	24.6	27.8	3.9	26.5	34.9	30.0	27.0	22.5	19.1	17.7	15.1	25.3	16.6	16.0	15.4	15.6	15.5	12.5
SLN	"MGC12301, MGC125854, MGC125855"	ENSG00000170290	Sarcolipin	O00631	11	107707378-107719693	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 446.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;HSkMC: 6.5;Karpas-707: 3.1;PC-3: 2.9;SCLC-21H: 2.0;U-2 OS: 3.0"	"Group enriched"	"Detected in many"	13	"glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 19.0"	"Low region specificity"	"Detected in many"			CAB011628			Approved	Microtubules				Microtubules	Microtubules	"CAB011628: AB_2195046"	"unprognostic (6.85e-2)"	"unprognostic (6.18e-8)"	"unprognostic (2.60e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.12e-3)"		"unprognostic (5.28e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (3.52e-9)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.09e-4)"	"unprognostic (3.77e-2)"	4.8	0.5	0.2	0.0	1.9	0.0	0.1	0.4	1.0	0.0	0.2	0.0	0.0	0.0	0.0	5.3	9.1	0.1	0.0	72.9	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	2.3	0.0	0.4	4.3	0.0	446.6	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.9	40.1	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.2	0.6	0.1	0.2	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.4	0.3	6.5	0.0	0.8	0.0	0.0	0.1	3.1	0.0	0.4	0.3	0.4	0.1	2.9	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	1.2	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	0.4	1.0	0.2	0.0	0.0	0.0	0.1	0.0
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888487-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 292.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;HEL: 1.5;HUVEC TERT2: 8.5;U-2197: 6.0"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.3	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.0	292.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	2.3	51.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044590-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 126.7"	"Group enriched"	"Detected in some"	5	"HSkMC: 8.1;SH-SY5Y: 2.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 3.0"	"Not detected"	"Not detected"														"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	5.7	0.4	0.3	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	126.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.7	25.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393216-17557792	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 165.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	5.8	4.1	13.8	3.0	20.1	0.7	3.9	7.5	26.4	5.6	7.7	1.9	2.0	1.9	9.2	5.9	7.0	5.8	3.8	31.2	19.9	8.7	3.3	2.0	2.1	1.1	5.3	17.3	2.1	1.6	3.2	1.7	6.2	8.6	8.4	3.6	2.9	2.5	10.1	165.7	0.9	2.6	13.1	2.0	1.6	3.3	1.1	1.3	0.0	2.3	14.5	1.3	4.6	6.4	0.0	0.0	0.0	0.0	0.0	2.9	0.1	5.4	8.4	16.3	19.6	0.1	0.0	3.5	19.3	14.1	15.9	14.5	2.8	2.4	0.0	18.2	20.7	2.8	7.2	7.2	23.0	0.0	2.7	0.0	5.4	9.2	1.5	0.0	0.0	1.2	3.5	8.0	3.5	0.7	0.0	0.0	33.5	8.7	0.0	0.0	6.2	4.8	1.8	21.7	0.3	8.3	2.2	2.1	4.1	6.5	21.0	11.4	23.2	3.9	0.0	12.9	12.3	0.3	16.9	0.0	0.0	0.0	4.2	0.0	17.5	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	20.1	7.5	26.4	19.9	8.7	5.3	17.3	8.6	1.3
CORO6	FLJ14871	ENSG00000167549	"Coronin 6"	Q6QEF8	17	29614756-29622907	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 130.9"	"Cell line enhanced"	"Detected in many"		"REH: 12.2;RH-30: 13.9;SH-SY5Y: 17.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"basophil: 3.9;eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021556			Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA021556: "	"unprognostic (7.12e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-4)"	"unprognostic (9.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.00e-4)"	"unprognostic (6.70e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (9.61e-7)"	"unprognostic (8.48e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.13e-2)"	2.7	1.6	5.7	1.2	17.7	0.9	2.2	4.5	12.4	1.4	4.4	0.7	1.6	1.3	3.3	3.4	6.9	3.5	2.4	28.4	5.2	3.3	0.9	0.8	2.1	1.0	1.8	8.7	1.2	1.0	11.7	1.0	25.7	8.1	4.0	1.7	1.2	3.8	2.7	130.9	2.0	2.4	5.6	1.3	1.1	2.1	1.0	3.6	0.0	21.3	18.3	1.1	4.9	1.9	0.0	0.0	3.9	0.0	0.0	0.1	0.1	7.5	3.3	2.9	0.0	4.6	2.5	4.7	2.5	0.9	1.6	0.7	0.2	0.0	0.1	0.6	4.0	8.0	2.2	0.4	0.8	0.1	3.8	0.0	6.3	0.9	7.5	0.0	0.4	9.1	0.7	0.8	0.0	1.7	0.5	0.1	5.4	0.0	5.0	0.2	1.0	0.1	12.2	13.9	0.3	0.4	0.0	0.0	17.1	0.7	2.3	0.0	0.0	1.1	0.5	1.1	0.0	1.3	1.1	6.4	3.4	0.9	2.4	0.0	0.0	3.9	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	17.7	4.5	12.4	5.2	3.3	1.8	8.7	8.1	3.6
DUSP26	"DUSP24, MGC1136"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591332-33600106	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 147.1"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 45.1"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	1.3	9.3	11.5	1.4	13.1	1.1	1.2	18.2	14.8	1.1	1.7	4.2	0.0	2.4	1.5	3.4	3.0	2.3	1.5	20.1	9.1	15.9	1.6	1.0	1.7	1.1	10.6	8.8	15.1	2.2	1.0	14.0	1.0	7.6	2.6	1.5	4.4	1.5	1.3	147.1	1.0	1.9	2.0	10.0	1.2	2.6	1.6	3.8	0.0	1.1	27.0	1.3	1.4	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	45.1	10.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.1	18.2	14.8	9.1	15.9	10.6	8.8	7.6	3.8
ENDOG		ENSG00000167136	"Endonuclease G"	Q14249	9	128818474-128822677	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021335, HPA021830"	Approved				"Intracellular and membrane"					"HPA021335: AB_1848151, HPA021830: AB_1848152"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.86e-2)"	"prognostic favourable (5.12e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.06e-7)"	"unprognostic (1.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	5.8	6.4	8.6	3.2	9.1	3.9	8.1	8.1	15.0	4.4	8.4	5.3	8.8	10.3	3.1	2.6	5.7	7.7	4.3	19.9	8.0	8.3	9.9	18.5	3.8	5.7	7.2	7.2	3.5	8.4	8.0	4.8	3.9	6.0	6.9	5.5	4.8	5.9	7.0	91.2	5.2	7.6	3.4	4.1	3.4	7.6	6.1	6.5	5.2	8.1	18.1	3.7	4.3	7.1	3.9	6.9	1.5	3.8	2.3	3.1	1.3	6.6	7.2	1.9	9.9	5.0	4.3	8.5	6.4	3.4	6.1	4.2	4.4	5.3	2.1	5.8	4.2	18.8	6.0	5.6	1.1	4.2	10.7	3.7	7.0	7.7	2.3	11.5	14.3	4.5	6.9	3.6	2.5	4.6	11.6	3.4	3.8	9.6	8.9	23.7	4.7	27.2	10.7	2.1	22.3	9.0	2.4	16.6	16.5	14.3	13.2	3.2	12.6	5.7	4.7	4.3	2.5	6.1	4.7	10.9	1.5	4.1	8.6	8.3	4.4	0.0	2.3	1.5	2.8	3.8	2.5	3.2	2.8	1.3	3.6	3.9	2.7	3.1	0.0	2.3	1.7	6.9	1.1	1.3	8.6	9.1	8.1	15.0	8.0	8.3	7.2	7.2	6.0	6.5
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 65.6"	"Cell line enhanced"	"Detected in many"		"A549: 12.6;HeLa: 35.3;RH-30: 12.0;U-87 MG: 12.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.6	3.0	1.2	0.2	1.3	0.1	2.4	0.4	1.2	9.7	0.6	2.5	11.1	0.4	2.6	1.9	0.7	8.3	0.7	6.2	1.5	1.2	6.1	0.4	2.0	0.2	2.1	0.8	1.6	0.4	0.2	7.2	0.2	3.5	6.6	0.4	2.7	0.8	13.9	65.6	0.4	0.5	1.9	3.5	0.6	0.7	7.4	1.4	1.8	2.5	5.5	0.7	2.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	1.2	0.0	0.0	0.0	0.0	0.0	10.1	0.2	1.5	0.0	0.0	0.0	10.0	0.0	0.0	7.6	3.2	0.0	0.0	9.9	1.3	35.3	0.0	0.3	0.0	3.4	2.6	0.0	7.3	2.2	0.0	0.0	5.4	4.0	0.0	0.0	0.0	0.0	0.7	0.1	12.0	0.0	0.0	1.9	1.8	2.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	9.0	3.6	1.6	0.0	12.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.4	1.2	1.5	1.2	2.1	0.8	3.5	1.4
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 200.5"	"Group enriched"	"Detected in some"	5	"HDLM-2: 59.7;U-251 MG: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdTCR: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA058955: , HPA065209: AB_2685433"	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	3.5	1.5	2.4	4.9	5.1	0.8	13.2	1.0	3.8	5.6	31.1	8.9	14.4	2.6	25.3	5.8	8.1	15.8	16.6	26.1	2.9	2.1	1.5	1.0	1.7	4.1	10.2	2.5	9.5	2.0	0.9	5.6	4.9	7.3	19.7	8.0	4.2	8.0	23.1	200.5	3.7	6.5	36.9	8.8	1.7	10.8	3.5	7.6	0.2	9.0	15.1	3.1	24.8	16.1	0.6	0.2	2.9	0.3	4.4	7.6	1.4	1.8	0.3	0.0	0.0	3.8	0.9	0.6	0.3	4.0	0.2	0.4	0.0	1.0	0.0	1.1	2.9	0.1	0.0	0.3	0.3	59.7	1.4	0.0	2.1	0.0	5.2	0.0	0.2	7.7	2.6	0.9	1.1	0.2	0.1	0.5	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.6	0.6	0.1	0.4	0.4	6.8	6.9	6.6	0.1	0.2	1.1	0.3	0.4	17.9	6.2	0.8	0.1	4.5	0.0	0.8	2.9	0.3	0.0	3.7	0.2	3.6	0.6	5.1	5.4	0.2	0.6	6.0	7.6	0.2	4.4	0.2	0.1	4.5	1.4	2.4	5.1	1.0	3.8	2.9	2.1	10.2	2.5	7.3	7.6
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		2200000000	2200000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavourable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	196.0	345.9	99.8	155.5	97.4	160.6	217.5	149.0	212.2	218.1	227.7	244.1	134.6	229.2	29.5	175.6	111.7	92.7	345.6	151.4	201.0	100.7	126.8	217.1	207.3	131.3	204.9	102.1	134.3	112.9	214.3	242.1	240.0	68.1	48.3	247.7	391.1	233.5	107.9	368.8	115.3	189.9	177.7	109.1	248.1	239.9	70.7	113.5	131.5	343.1	197.9	53.6	144.8	149.7	170.2	205.7	87.8	257.4	109.8	79.8	295.4	360.8	129.9	266.3	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321328	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 97.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.2;RT4: 9.0;SK-BR-3: 24.3;T-47d: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favourable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	1.7	0.6	1.8	0.7	5.7	0.5	0.8	13.7	3.1	0.8	1.9	0.8	0.4	0.8	1.5	1.7	1.8	0.6	0.6	3.3	2.1	0.7	0.8	0.5	2.2	0.5	1.0	4.2	0.5	3.5	1.1	0.4	1.1	2.4	1.8	2.8	0.0	1.3	0.8	97.2	0.7	0.9	1.4	2.4	0.5	0.9	0.9	2.3	2.4	1.2	21.5	1.4	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.4	0.1	3.1	0.0	1.0	0.0	4.6	3.9	3.1	1.0	0.0	5.9	0.0	3.7	0.0	0.5	2.0	0.2	0.6	2.6	0.0	2.9	0.0	0.5	0.0	0.3	2.8	10.2	0.0	6.8	2.0	5.2	3.9	0.0	0.1	9.0	5.2	0.7	0.0	24.3	1.2	17.3	0.1	0.0	1.2	1.7	0.4	1.0	0.0	0.0	0.0	2.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.7	13.7	3.1	2.1	0.7	1.0	4.2	2.4	2.3
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium voltage-gated channel subfamily J member 11"	Q14654	11	17385859-17389331	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 63.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;HEK 293: 13.4;MCF7: 10.7;SCLC-21H: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048891	Approved									"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favourable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.5	1.1	2.9	1.0	7.8	0.8	2.7	13.6	7.8	1.0	1.1	0.7	4.9	1.4	1.1	2.1	1.7	1.1	1.1	6.2	3.5	2.4	1.3	0.9	1.3	1.2	2.7	5.2	0.8	8.7	2.7	3.3	0.7	3.5	2.5	1.0	0.1	1.2	7.6	63.1	1.0	1.1	0.8	1.7	1.0	4.6	0.8	1.9	0.0	4.1	4.5	1.0	0.9	1.1	0.8	0.4	1.4	0.3	0.8	0.4	0.4	1.5	2.3	0.3	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	2.5	0.2	7.1	0.2	0.0	0.3	4.8	0.1	0.3	1.6	13.4	3.6	0.9	0.8	0.1	0.4	0.3	0.1	0.3	0.0	0.1	0.0	3.7	3.8	0.0	10.7	0.7	0.1	1.0	0.3	1.4	1.7	2.0	0.4	0.9	9.1	0.8	0.0	3.5	0.0	4.6	0.2	0.0	0.0	1.2	0.0	0.1	0.2	6.0	0.9	0.0	1.0	0.0	1.4	0.3	0.2	0.4	0.3	0.3	0.7	0.4	0.4	0.1	0.8	0.4	0.4	1.3	0.8	0.1	0.4	0.3	0.4	2.9	7.8	13.6	7.8	3.5	2.4	2.7	5.2	3.5	1.9
MACROD1	LRP16	ENSG00000133315	"MACRO domain containing 1"	Q9BQ69	11	63998558-64166106	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 142.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 26.5;RPMI-8226: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favourable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	4.9	3.0	2.9	2.8	3.3	2.5	3.9	6.2	4.6	3.6	6.9	2.8	7.0	4.3	3.4	6.5	7.8	3.2	3.9	29.0	2.2	3.4	10.6	10.4	3.0	1.8	3.0	3.1	5.2	16.6	2.5	2.7	2.1	3.1	6.1	1.9	4.6	16.4	8.1	142.5	5.5	3.9	6.2	2.4	2.7	5.6	1.9	2.7	0.8	12.7	25.0	3.3	4.6	4.5	0.6	0.7	0.0	1.2	0.0	2.0	0.4	3.9	2.1	0.6	3.7	0.6	0.4	3.6	2.3	1.1	1.9	1.7	2.0	10.8	15.1	8.3	0.2	10.2	0.5	0.0	0.1	1.1	7.1	5.4	8.6	10.7	2.2	4.5	0.6	0.9	1.2	0.2	0.5	0.6	4.9	3.0	0.3	26.5	6.2	15.6	1.8	8.0	5.6	4.3	50.0	0.6	0.2	5.2	10.8	2.1	15.6	14.2	11.2	0.1	1.0	1.7	2.5	2.5	0.2	6.1	0.9	2.4	1.1	4.6	1.5	0.0	0.2	0.0	2.0	1.2	1.9	0.6	1.8	1.1	0.4	0.4	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.4	2.9	3.3	6.2	4.6	2.2	3.4	3.0	3.1	3.1	2.7
MAFA	"hMafA, RIPE3b1"	ENSG00000182759	"MAF bZIP transcription factor A"	Q8NHW3	8	143419182-143430406	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;MCF7: 4.4;RH-30: 2.7;SCLC-21H: 6.4;T-47d: 6.1;U-2 OS: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"amygdala: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"														"unprognostic (5.92e-3)"	"unprognostic (9.89e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.42e-8)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-2)"	0.2	0.1	2.5	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.2	0.0	0.0	0.1	0.1	0.3	0.6	0.1	0.1	2.1	0.4	0.2	0.3	0.1	0.7	0.1	0.1	0.2	0.1	2.2	0.2	0.5	1.8	0.9	0.3	0.1	0.7	0.4	0.1	25.6	0.1	0.1	0.1	0.7	0.1	0.1	3.4	0.0	0.4	2.5	5.5	0.4	0.1	0.1	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.7	0.9	0.0	0.0	0.1	1.8	0.9	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.0	4.4	0.1	0.6	0.6	0.4	0.6	2.7	0.4	0.0	0.0	6.4	0.2	1.5	0.0	0.0	6.1	0.1	0.0	0.1	4.2	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	2.5	0.2	0.0	0.6	0.4	0.2	0.1	0.2	0.9	0.0
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"		22	25742144-26031041	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 141.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.6;REH: 10.9;RH-30: 23.3;U-2 OS: 10.3;U-266/70: 7.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	1.0	0.0	141.2	0.1	0.0	1.5	0.0	0.0	0.3	2.4	0.0	0.3	1.1	16.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	3.9	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.9	0.7	2.9	0.0	0.3	1.1	0.0	0.0	10.9	23.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083132-203086036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 60.0"	"Group enriched"	"Detected in some"	200	"HSkMC: 17.6;RH-30: 33.6"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028336			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028336: AB_2672562"	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	2.4	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.7	13.3	1.7	0.0	0.0	0.8	0.8	2.3	1.3	1.8	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.8	0.4	0.7	1.0	0.8	0.5	0.6	0.3	0.6	0.9	1.0	1.4	1.8	1.3	0.8	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 198.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.36e-2)"	"prognostic favourable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favourable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	22.4	17.6	15.3	10.1	17.6	9.9	7.0	16.6	22.7	6.1	18.7	20.6	7.6	34.5	7.1	9.6	13.3	6.7	10.0	35.9	16.1	15.1	20.7	20.7	7.1	9.1	19.6	11.9	7.2	28.7	5.0	12.0	6.8	17.6	11.9	4.0	12.0	23.6	10.2	198.0	8.3	25.2	7.5	20.1	11.5	18.2	14.2	14.6	9.7	8.0	39.2	10.0	6.7	7.9	29.1	41.8	19.8	39.1	17.2	29.2	20.8	18.2	18.5	0.6	4.3	0.6	1.7	9.5	11.0	1.1	2.3	2.5	30.3	4.5	27.0	11.3	0.6	9.6	0.8	2.2	0.1	30.1	21.3	8.5	19.8	18.8	2.8	14.7	9.5	1.4	3.8	0.4	0.0	3.2	16.8	10.6	0.6	19.1	14.6	6.1	6.6	22.9	14.2	7.1	27.5	1.1	14.1	10.4	10.6	9.7	9.2	17.9	7.3	9.2	13.8	4.4	6.1	9.6	14.2	42.7	37.2	18.3	11.1	19.9	6.2	19.8	33.6	16.1	21.3	39.1	18.1	29.1	20.1	20.0	41.8	27.1	19.7	19.1	9.1	17.2	31.7	31.6	29.2	20.8	15.3	17.6	16.6	22.7	16.1	15.1	19.6	11.9	17.6	14.6
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 170.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol				Cytosol	Cytosol	"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	19.3	21.4	16.1	8.4	15.4	9.6	17.9	17.1	20.4	9.5	11.8	9.4	5.8	14.3	9.4	6.9	14.5	7.3	10.1	32.5	11.9	13.6	16.6	16.7	12.0	9.5	16.2	18.0	22.1	8.2	8.9	9.9	13.0	21.0	9.9	13.4	5.8	10.2	10.2	170.7	17.6	16.0	10.3	16.9	12.4	12.7	16.0	12.5	4.9	6.4	24.5	8.4	11.0	19.8	6.0	1.8	11.9	1.1	16.0	34.5	9.2	18.5	5.3	3.0	4.1	41.1	42.4	3.5	22.4	25.6	17.0	28.2	9.3	24.9	0.1	8.9	30.5	17.4	3.9	21.5	13.0	43.2	2.1	3.8	7.4	5.0	42.1	0.1	14.0	22.7	17.0	16.2	17.0	14.4	4.7	28.8	22.8	3.9	1.8	0.5	1.2	2.4	0.3	5.9	1.9	20.7	13.3	0.8	3.2	19.4	5.9	14.5	12.7	2.6	39.2	14.0	6.9	18.9	6.2	14.9	5.1	0.1	21.0	3.2	2.6	11.9	0.8	0.1	19.7	0.5	15.0	6.0	24.9	22.6	0.1	3.4	10.1	12.3	0.7	16.0	1.1	1.8	34.5	9.2	16.1	15.4	17.1	20.4	11.9	13.6	16.2	18.0	21.0	12.5
OR9Q1		ENSG00000186509	"Olfactory receptor family 9 subfamily Q member 1"	Q8NGQ5	11	58023881-58181616	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"skeletal muscle: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (2.65e-3)"	"unprognostic (2.27e-1)"				0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.1		0.0	0.0		0.1	0.0	3.1	0.5	0.0	0.0	0.0	0.1	0.0	0.6			0.0		0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.4	0.3	0.7	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.3	0.2	0.2	0.1	0.1	0.1	0.8	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0										
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535612	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 447.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 50.0;RH-30: 12.3;U-266/70: 40.2;U-266/84: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		270000	270000	Cytosol	Cytosol	"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.78e-3)"	7.8	1.2	1.6	5.2	1.9	0.1	3.7	2.2	1.0	6.6	16.5	1.4	7.9	2.3	22.2	17.0	27.2	9.3	9.9	29.5	1.5	1.6	0.8	0.8	5.6	1.4	1.6	1.0	11.1	2.1	0.1	1.9	2.2	1.6	15.2	3.6	4.8	5.3	18.7	447.7	1.0	6.1	49.5	1.4	3.4	10.2	3.9	0.7	0.1	6.2	87.3	9.1	28.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	1.9	5.5	0.0	0.0	3.9	0.0	1.2	0.0	4.1	0.0	0.0	50.0	0.0	0.0	0.0	0.9	0.3	0.0	12.3	0.1	0.0	0.0	7.4	5.6	0.0	0.0	2.9	0.2	0.0	2.7	0.0	3.0	0.0	2.5	40.2	11.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	2.2	1.0	1.5	1.6	1.6	1.0	1.6	0.7
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 284.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		1100000	1100000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavourable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favourable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	4.4	11.6	10.0	3.0	16.2	2.3	3.9	13.0	23.6	5.8	5.3	6.1	5.4	3.0	6.4	5.8	9.1	5.4	4.8	55.5	8.2	10.1	10.9	2.7	3.6	2.4	9.4	10.8	10.8	3.0	14.2	11.4	3.3	17.9	7.1	4.2	10.8	5.2	9.4	284.3	2.6	2.8	8.3	4.6	2.7	4.1	10.3	3.8	0.0	5.5	54.9	4.6	5.3	3.7	10.7	6.7	8.7	3.2	2.2	5.4	3.5	8.7	8.5	27.0	24.6	27.6	20.1	5.5	23.7	21.8	20.5	14.6	21.0	11.0	52.2	19.7	11.5	9.8	23.4	23.9	19.3	1.2	12.2	14.9	19.4	0.7	14.8	0.7	8.6	28.4	14.1	18.0	29.7	23.3	17.8	26.4	18.9	6.6	18.3	1.2	19.3	26.5	30.9	15.8	40.1	14.0	9.7	32.0	23.5	14.0	22.3	23.7	22.5	3.2	20.9	9.5	13.2	13.9	19.7	14.4	38.4	28.6	18.4	1.5	8.0	0.4	3.2	8.7	2.5	2.8	1.0	10.7	4.3	2.4	6.7	7.0	5.4	3.0	0.8	2.2	2.3	1.0	3.8	3.5	10.0	16.2	13.0	23.6	8.2	10.1	9.4	10.8	17.9	3.8
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		540000000	540000000	Cytosol	Cytosol	"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (1.30e-4)"	"prognostic unfavourable (2.74e-6)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.5	209.8	42.3	50.0	50.9	57.2	35.0	88.5	206.7	142.1	143.9	59.0	100.5	62.1	89.6	165.6	118.9	133.7	180.0	111.4	109.0	63.2	38.0	105.5	48.8	35.5	49.3	82.0	51.9	83.9	109.5	45.0	83.6	9.5	49.8	224.1	50.7	18.4	21.2	52.3	80.1	54.7	135.4	118.3	188.7	105.0	44.0	48.0	115.4	71.2	90.5	49.9	35.9	65.1	161.9	88.6	158.2	160.5	64.0	90.4	54.7	199.3	81.6	158.6	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4
PPDPFL	C8orf22	ENSG00000168333	"Pancreatic progenitor cell differentiation and proliferation factor like"	Q8WWR9	8	49054311-49076090	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 311.2"	"Cell line enriched"	"Detected in single"	10	"HEL: 5.6"	"Group enriched"	"Detected in some"	9	"glioma: 0.7;renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060329	Uncertain									"HPA060329: AB_2684255"					"unprognostic (6.33e-2)"							"unprognostic (2.72e-1)"	"prognostic unfavourable (2.06e-10)"					0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.1	311.2	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	57.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633054	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 259.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.3;HHSteC: 21.9;LHCN-M2: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain									"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	4.0	5.4	10.4	2.8	18.9	1.5	3.5	1.1	15.8	24.9	4.1	8.0	8.3	2.7	7.1	6.5	26.5	4.5	6.0	53.3	13.1	5.7	5.4	39.5	5.4	1.8	6.1	8.1	6.6	5.6	2.8	1.7	6.3	12.2	11.0	2.8	4.5	10.0	13.4	259.9	4.4	2.2	14.8	9.1	2.2	5.2	2.2	6.1	0.0	2.4	28.2	7.7	11.4	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.7	10.9	5.0	2.4	0.0	12.1	9.4	4.9	5.3	0.0	0.9	0.0	0.5	11.2	0.6	0.2	1.3	9.2	0.0	0.0	0.1	17.3	1.9	21.9	0.0	0.0	8.1	2.1	3.1	0.2	1.2	5.6	0.0	41.9	0.4	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.4	10.5	0.3	0.7	0.0	0.0	0.0	0.0	1.8	8.2	2.2	2.2	2.9	1.7	0.0	0.2	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	18.9	1.1	15.8	13.1	5.7	6.1	8.1	12.2	6.1
PRKAG3		ENSG00000115592	"Protein kinase AMP-activated non-catalytic subunit gamma 3"	Q9UGI9	2	218822383-218832086	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 40.4"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 2.3;HSkMC: 4.6;LHCN-M2: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (3.51e-1)"	"unprognostic (4.41e-3)"		"unprognostic (2.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.86e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.97e-1)"	"unprognostic (7.69e-2)"	2.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	40.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	8.2	0.7	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043010	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.1	1.8	1.6	4.7	0.3	9.3	4.7	3.1	3.3	3.7	2.7	7.1	6.9	14.1	9.1	0.4	0.1	2.3	1.3	2.4	2.0	3.6	0.9	1.8	1.3	2.7	4.3	1.1	0.8	0.4	1.6	3.1	10.5	0.7	3.6	7.1	4.9	0.7	4.7	9.7	2.0	10.2	0.3	3.4	8.9	18.6	1.7	2.1	1.2	1.8	3.6	2.3	27.3	13.3	3.1	2.3	16.6	10.2	6.1	3.4	3.0	3.3	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1										
SH3BGR	21-GARP	ENSG00000185437	"SH3 domain binding glutamate rich protein"	P55822	21	39445855-39515506	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 219.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 15.3;U-87 MG: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7"	"Low region specificity"	"Detected in all"			"CAB003685, HPA030690"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB003685: AB_425682, HPA030690: AB_2673570"	"unprognostic (3.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.68e-3)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.75e-1)"	"unprognostic (5.98e-3)"	"unprognostic (7.16e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.06e-2)"	2.4	5.2	7.2	1.2	7.3	0.9	2.9	1.1	4.3	2.9	6.1	3.0	2.0	1.9	2.1	6.6	5.3	2.1	5.0	30.0	6.6	5.4	3.2	2.8	1.5	0.9	7.5	5.0	1.8	2.8	2.1	4.5	1.1	6.1	5.8	2.0	1.2	3.2	5.2	219.7	0.9	1.4	12.4	7.9	1.2	2.9	3.7	5.9	0.1	3.9	41.5	2.2	7.3	8.6	2.7	11.5	2.6	1.7	2.8	4.0	1.2	1.0	1.3	1.7	2.5	3.7	4.3	0.5	1.9	0.9	0.9	0.7	0.7	2.2	3.3	5.1	5.0	0.1	0.9	1.5	1.4	2.0	3.4	3.3	0.6	1.3	7.6	1.2	0.7	3.5	6.2	3.2	6.3	1.0	2.5	4.3	3.5	4.1	2.2	1.9	1.7	2.9	3.5	6.4	2.1	4.6	0.8	4.8	2.0	2.9	2.4	3.1	9.0	0.6	0.8	2.5	0.3	1.5	3.7	15.3	3.2	3.3	47.5	2.9	3.3	2.3	0.7	0.0	1.2	1.7	3.1	2.7	1.1	1.8	1.9	1.4	4.0	3.0	2.6	2.8	1.7	11.5	0.7	1.2	7.2	7.3	1.1	4.3	6.6	5.4	7.5	5.0	6.1	5.9
SHISA4	"C1orf40, hShisa4, TMEM58"	ENSG00000198892	"Shisa family member 4"	Q96DD7	1	201888680-201892306	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 175.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 18.3;monocytes: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061273, HPA067885"	Uncertain									"HPA061273: AB_2684460, HPA067885: "	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.48e-3)"	"unprognostic (2.12e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.06e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"	5.2	15.8	22.2	3.8	18.8	2.5	3.3	9.6	34.8	4.7	3.3	29.1	2.1	2.7	4.4	4.5	4.0	3.9	4.7	14.7	17.5	14.6	4.1	3.8	4.0	2.7	19.2	14.8	6.8	4.1	4.1	3.8	3.8	21.3	6.2	2.9	7.2	12.1	5.1	175.2	4.2	3.2	4.7	14.0	3.4	3.2	4.2	8.2	0.0	6.3	18.8	2.7	3.9	2.6	0.0	0.7	18.3	7.8	0.0	1.5	0.5	1.2	9.4	1.1	6.7	10.2	6.1	1.0	8.2	13.4	3.4	4.8	1.6	2.5	0.0	11.2	10.1	2.4	0.1	1.3	2.2	1.0	0.6	0.1	2.8	1.1	7.2	0.0	6.0	6.2	3.0	4.4	2.2	6.2	0.1	0.3	6.0	1.1	0.0	0.0	0.7	11.4	0.1	0.0	1.8	3.3	3.6	0.4	6.1	2.9	1.3	8.3	3.8	0.8	6.2	4.8	4.8	2.7	4.2	1.6	1.3	0.0	7.9	0.0	8.4	0.0	1.4	18.3	1.5	6.4	0.6	0.0	0.3	0.3	0.7	0.0	0.0	0.3	8.2	0.0	7.8	0.0	0.0	0.5	22.2	18.8	9.6	34.8	17.5	14.6	19.2	14.8	21.3	8.2
STK25	"SOK1, YSK1"	ENSG00000115694	"Serine/threonine kinase 25"	O00506	2	241492674-241509730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 164.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047147	Uncertain									"HPA047147: AB_10966137"	"unprognostic (1.75e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (3.91e-8)"	"unprognostic (6.16e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.58e-1)"	17.8	13.6	22.3	14.2	26.0	16.3	12.9	22.3	35.3	16.4	17.1	17.0	13.0	14.6	17.7	15.9	19.3	15.4	16.7	19.0	19.4	20.0	17.3	13.5	13.4	13.5	16.3	20.4	17.5	19.2	18.9	17.1	15.6	16.4	15.1	12.9	13.5	14.2	17.6	164.2	15.3	14.2	17.3	12.6	15.8	16.1	16.8	14.4	15.2	20.0	24.6	12.6	14.6	16.6	15.0	13.6	13.7	16.4	21.5	19.9	10.6	18.3	11.7	23.4	29.0	28.8	20.1	36.0	30.7	20.7	23.4	26.8	13.0	16.2	7.0	8.7	40.9	15.7	32.9	33.4	28.5	26.2	34.5	19.6	24.8	33.6	26.1	11.9	15.1	28.9	24.0	22.6	18.2	52.8	30.2	6.2	42.8	19.3	17.6	18.5	32.6	16.8	29.7	29.8	10.4	20.6	15.6	39.3	18.0	14.9	11.3	19.2	9.0	21.1	61.5	17.7	21.7	20.3	21.7	12.9	2.9	11.9	17.1	9.8	20.0	13.7	14.8	11.5	16.9	13.4	15.5	14.5	15.5	17.5	13.6	15.0	12.0	11.6	5.5	21.5	16.4	10.7	19.9	10.6	22.3	26.0	22.3	35.3	19.4	20.0	16.3	20.4	16.4	14.4
TBX1	"CATCH22, VCF"	ENSG00000184058	"T-box 1"	O43435	22	19756703-19783593	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 36.5"	"Cell line enhanced"	"Detected in some"		"HEK 293: 9.9;K-562: 47.6;NB-4: 11.2;TIME: 15.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 3.0"	"Group enriched"	"Detected in some"	13	"basophil: 1.0;eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029330			Approved	"Nuclear bodies,Cytoplasmic bodies"				"Nuclear bodies, Cytoplasmic bodies"	"Nuclear bodies, Cytoplasmic bodies"	"HPA029330: AB_2673002"	"unprognostic (2.54e-1)"	"unprognostic (4.28e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-3)"	"unprognostic (9.14e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.31e-2)"	"prognostic favourable (8.90e-4)"	1.4	0.2	0.6	0.6	3.0	0.0	3.7	0.6	0.6	2.5	2.3	0.6	0.6	0.4	0.9	0.6	2.5	2.8	0.6	0.6	0.6	0.0	0.6	0.6	2.2	1.7	0.6	0.6	0.7	0.6	3.7	0.6	0.6	0.6	2.3	0.2	0.6	3.4	0.6	36.5	4.6	0.8	0.6	0.6	0.6	0.1	7.0	0.6	0.6	5.3	0.6	1.9	1.1	3.3	0.0	0.1	2.7	0.0	0.0	0.1	0.0	5.9	0.6	0.1	4.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.3	5.1	4.4	0.0	0.2	9.9	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	47.6	0.0	3.2	1.1	0.1	11.2	0.7	6.9	0.1	4.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	2.0	3.0	15.2	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.0	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6
TMEM38A	"MGC3169, TRIC-A"	ENSG00000072954	"Transmembrane protein 38A"	Q9H6F2	19	16661127-16690029	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 158.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 12.1;U-266/70: 12.2;U-698: 20.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048100, HPA050463"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA048100: , HPA050463: AB_2681137"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.49e-1)"	"prognostic favourable (2.78e-5)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"prognostic favourable (2.99e-10)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.96e-2)"	1.3	1.6	3.6	1.1	7.9	2.3	1.2	5.1	12.2	1.3	1.4	2.1	3.1	1.3	1.1	6.6	3.5	1.8	1.0	5.4	3.0	3.8	2.0	2.7	2.1	1.3	5.2	3.7	1.2	1.3	1.7	2.2	0.9	4.8	2.9	1.5	8.3	2.7	2.4	158.8	1.0	1.1	1.1	1.9	1.0	5.3	1.6	1.4	0.0	1.8	30.1	1.9	1.1	0.4	3.9	0.5	20.3	2.9	2.1	0.5	0.6	3.0	0.6	0.8	4.7	2.6	0.3	0.4	1.1	0.6	0.7	1.5	0.9	4.4	12.1	1.9	0.2	2.5	6.2	1.3	0.7	0.8	1.8	0.0	1.8	1.0	0.7	0.1	0.2	1.1	4.8	0.9	0.5	0.3	0.1	1.1	0.5	4.6	0.1	1.2	1.2	7.2	6.3	1.1	3.2	4.6	2.3	7.8	5.4	3.3	0.4	1.5	2.3	1.0	0.0	0.9	2.3	2.9	0.5	12.2	8.8	20.3	1.1	7.2	0.9	20.3	2.9	8.2	0.0	1.1	0.0	2.8	0.4	0.0	0.2	3.9	0.1	0.1	1.6	2.1	0.7	0.5	0.5	0.6	3.6	7.9	5.1	12.2	3.0	3.8	5.2	3.7	4.8	1.4
TNNC2		ENSG00000101470	"Troponin C2, fast skeletal type"	P02585	20	45823214-45833745	"FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 851.6"	"Group enriched"	"Detected in some"	7	"Hep G2: 9.7;HSkMC: 15.3;SCLC-21H: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043174, HPA058481"	Enhanced		Approved	Nucleoplasm,Vesicles		63000	63000	Nucleoplasm	Nucleoplasm	"HPA043174: AB_10806380, HPA058481: AB_2683729"	"unprognostic (1.13e-1)"	"unprognostic (7.25e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.12e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.03e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.13e-1)"	12.0	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	2.7	4.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.4	0.1	0.0	7.8	0.1	851.6	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	169.1	6.6	0.1	0.1	6.0	0.8	2.4	1.1	0.3	4.1	11.9	0.1	0.0	0.2	0.5	1.7	1.2	1.7	0.2	0.4	0.0	0.1	0.2	1.1	0.4	1.2	1.0	0.4	0.0	0.4	0.0	0.0	0.3	0.0	0.9	9.7	0.4	0.3	0.2	15.3	0.2	0.1	0.7	0.0	0.1	0.5	0.2	1.2	0.7	0.1	0.0	0.6	0.2	0.6	0.2	0.3	0.0	11.5	0.5	1.7	0.1	0.4	1.3	0.4	0.5	0.3	0.4	0.9	0.2	1.5	0.4	0.3	1.6	0.1	0.2	0.0	0.7	1.4	0.2	1.1	0.7	6.0	1.5	0.2	0.3	3.8	0.0	0.3	2.4	0.3	0.8	0.8	4.1	11.9	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282392-27307439	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 187.1"	"Group enriched"	"Detected in some"	9	"HAP1: 8.2;NTERA-2: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Cell type enriched"	"Detected in single"	16	"NK-cell: 7.0"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 7.0"	"Region enhanced"	"Detected in some"		"amygdala: 3.2"	"Group enriched"	"Detected in some"	11	"cerebral cortex: 1.4;hippocampal formation: 0.8"	HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	2.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.9	0.1	6.3	1.6	0.0	0.0	35.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	187.1	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.3	40.3	2.2	0.1	0.0	0.3	0.0	0.0	0.0	7.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	1.4	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.6	0.0	0.6	0.7	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0
ASB5		ENSG00000164122	"Ankyrin repeat and SOCS box containing 5"	Q8WWX0	4	176213673-176277571	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 133.4"	"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 161.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028870			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA028870: "					"unprognostic (1.76e-1)"	"prognostic unfavourable (5.67e-4)"		"unprognostic (1.90e-1)"			"unprognostic (7.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"		"unprognostic (6.80e-3)"	2.3	0.0	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.3	3.5	0.0	0.0	0.1	0.2	6.3	7.9	0.0	0.4	1.3	0.2	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.6	1.3	0.0	8.0	0.1	133.4	0.0	0.5	23.5	1.0	0.0	2.0	2.2	0.0	0.0	2.3	31.4	2.2	15.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	3.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	161.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.0
ATP5F1D	ATP5D	ENSG00000099624	"ATP synthase F1 subunit delta"	P30049	19	1241746-1244826	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 337.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002865	Approved					4200000	4200000			"HPA002865: AB_1078244"	"unprognostic (4.80e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.77e-2)"	"prognostic favourable (1.23e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (3.46e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	30.4	25.7	27.4	13.7	30.1	19.5	19.8	22.6	51.7	14.4	36.7	16.7	16.0	42.7	14.3	14.9	23.9	15.3	18.1	59.3	25.9	20.6	33.3	51.8	12.2	33.4	25.6	24.1	15.2	46.5	15.5	18.4	12.4	28.5	17.6	14.1	17.9	48.1	23.1	337.3	24.3	33.2	21.1	14.5	19.2	33.4	10.2	9.8	21.5	23.0	60.6	22.9	17.6	14.5	67.7	78.2	33.9	64.6	52.8	64.3	50.8	24.2	13.3	4.1	15.5	4.8	7.2	15.6	16.7	7.1	9.9	7.3	13.9	6.5	24.7	10.8	5.8	20.9	4.6	17.3	1.3	17.0	45.2	14.9	16.4	18.1	12.1	26.0	22.2	14.2	4.8	4.0	5.5	10.5	21.6	19.8	4.5	36.9	28.2	18.8	18.1	65.7	27.0	11.0	51.3	16.5	16.0	16.6	19.1	11.1	17.7	27.5	13.2	12.4	15.1	9.1	12.4	21.7	13.8	50.6	25.5	9.2	16.7	12.3	13.6	33.9	64.6	27.1	50.7	61.3	61.1	64.8	64.3	55.7	72.1	67.7	59.9	54.9	22.5	52.8	49.0	78.2	62.0	50.8	27.4	30.1	22.6	51.7	25.9	20.6	25.6	24.1	28.5	9.8
CAND2	"KIAA0667, TIP120B, Tp120b"	ENSG00000144712	"Cullin associated and neddylation dissociated 2 (putative)"	O75155	3	12796472-12871916	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 76.2"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.2;REH: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005777	Approved		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nuclear bodies"	"HPA005777: AB_2667431"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.03e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.78e-5)"	"unprognostic (1.31e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-3)"	2.9	2.8	6.4	1.4	7.6	1.4	1.4	7.2	11.8	2.3	3.2	3.7	0.5	1.5	3.7	2.6	2.6	3.6	2.1	17.8	4.7	4.3	1.7	1.7	1.9	1.4	2.7	5.5	3.3	2.5	6.4	4.9	1.4	3.1	3.0	1.4	4.2	2.2	3.4	76.2	1.6	1.7	5.2	2.2	2.2	2.1	11.4	2.6	0.1	2.4	11.1	1.2	3.0	5.0	1.2	0.2	0.7	0.5	0.0	2.2	0.6	0.7	1.5	5.8	0.2	0.2	0.1	0.3	1.6	0.6	3.1	4.2	0.8	0.3	0.9	1.7	0.8	0.2	6.4	0.1	2.8	1.6	18.2	1.3	2.2	1.2	4.9	0.1	0.1	1.3	0.3	3.0	0.1	0.7	4.7	0.9	0.9	2.9	2.3	0.7	4.0	1.8	11.2	1.1	0.9	0.2	1.3	3.9	5.2	0.1	0.8	1.0	1.7	5.5	0.4	0.9	1.0	0.9	1.2	1.5	8.9	8.6	0.5	1.1	1.9	0.0	0.5	0.0	1.2	0.2	0.6	1.2	0.6	2.2	0.1	0.5	1.3	0.9	0.7	0.0	0.1	0.2	1.6	0.6	6.4	7.6	7.2	11.8	4.7	4.3	2.7	5.5	3.1	2.6
CCDC28B	"MGC1203, RP4-622L5.5"	ENSG00000160050	"Coiled-coil domain containing 28B"	Q9BUN5	1	32200386-32205387	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 66.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 140.1"	"Low region specificity"	"Detected in all"			HPA028589	Uncertain									"HPA028589: AB_10602175"	"prognostic favourable (2.92e-4)"	"unprognostic (6.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.50e-3)"	"unprognostic (7.87e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.79e-2)"	"prognostic favourable (1.10e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.07e-2)"	2.0	6.5	7.0	4.1	7.2	3.4	1.6	12.4	6.5	2.2	3.1	2.0	1.4	2.4	3.1	3.2	3.2	2.7	3.9	8.6	6.3	4.6	2.9	1.1	2.0	6.8	5.0	6.0	3.4	3.5	4.4	10.1	3.0	4.3	2.7	1.7	4.7	4.0	2.6	66.7	2.6	1.9	3.8	3.6	3.4	2.8	11.7	5.2	4.5	3.2	11.7	4.7	3.2	1.9	9.3	14.2	3.1	4.3	15.8	15.6	8.4	4.6	1.6	10.3	9.9	3.0	3.9	0.8	3.3	4.8	5.9	4.0	3.0	5.3	10.3	5.4	4.0	1.3	8.3	3.9	1.1	11.7	11.8	13.3	7.2	1.8	4.3	0.3	4.6	4.7	1.8	6.6	0.1	8.0	8.5	1.3	3.9	0.6	17.3	2.6	10.5	2.5	18.4	5.0	8.3	5.3	0.7	20.1	8.9	4.8	1.0	5.8	3.2	3.9	4.7	3.4	4.4	4.5	2.1	2.8	0.7	0.6	5.6	17.9	3.2	3.1	4.3	0.9	15.6	2.0	7.8	7.8	7.4	13.2	9.8	9.3	12.4	12.3	0.4	15.8	0.5	14.2	9.6	8.4	7.0	7.2	12.4	6.5	6.3	4.6	5.0	6.0	4.3	5.2
COQ8A	"ADCK3, CABC1, COQ8, SCAR9"	ENSG00000163050	"Coenzyme Q8A"	Q8NI60	1	226897536-226987545	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 216.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 33.0;RPMI-8226: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061662			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA061662: AB_2684578"	"unprognostic (6.37e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.15e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.62e-1)"	13.3	25.4	2.8	2.7	4.5	5.3	8.5	14.5	3.9	3.2	7.3	4.1	4.2	6.9	3.6	5.5	7.3	5.0	6.1	41.0	2.7	1.8	3.8	17.7	2.7	4.1	5.0	2.4	7.2	20.3	1.6	1.6	2.0	3.8	6.5	2.0	1.9	7.2	5.0	216.5	4.4	4.4	7.8	2.9	3.5	8.8	3.0	4.7	2.7	4.6	50.2	5.8	10.2	3.5	15.2	9.3	32.3	11.5	9.9	11.8	11.6	3.2	5.8	1.5	4.5	4.7	3.1	23.6	1.5	1.3	2.2	2.9	9.2	5.2	9.5	7.3	1.0	3.7	2.9	3.3	0.5	9.9	33.0	6.6	4.8	15.1	1.0	10.0	4.1	5.9	5.1	1.7	2.3	1.0	11.4	7.8	0.3	4.3	5.8	14.7	6.4	12.0	5.7	7.1	30.2	0.7	2.4	24.3	9.9	3.0	11.8	8.5	6.2	13.6	1.2	2.5	2.3	3.5	5.5	17.6	15.4	5.0	2.3	11.4	2.4	19.7	11.5	32.3	8.7	8.6	8.3	12.1	8.5	7.7	9.3	15.2	11.8	9.0	21.9	9.9	6.5	4.1	10.6	11.6	2.8	4.5	14.5	3.9	2.7	1.8	5.0	2.4	3.8	4.7
KLHL33		ENSG00000185271	"Kelch like family member 33"	A6NCF5	14	20425852-20436158	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 39.2"	"Cell line enriched"	"Detected in some"	9	"REH: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 9.3"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 9.3"	"Low region specificity"	"Detected in many"							"HPA049985, HPA056560"	Enhanced									"HPA049985: , HPA056560: AB_2683174"	"unprognostic (6.92e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.32e-5)"	"unprognostic (2.32e-1)"	1.2	0.1	0.1	0.1	0.1	0.0	0.3	0.6	0.6	0.6	0.4	0.3	0.1	0.0	0.8	0.7	0.4	0.4	0.3	0.5	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.6	0.1	0.7	0.1	0.1	0.4	0.5	0.0	0.1	0.8	0.5	39.2	0.0	0.3	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	8.5	0.6	0.3	0.8	0.3	9.3	0.3	0.1	0.1	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.3	0.1	0.2	0.4	0.7	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.2	0.4	0.0	9.3	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.1	0.1	0.2	0.4	0.2	1.0	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.6	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.3	0.2	0.1	0.0	9.3	0.0	0.2	0.1	0.1	0.6	0.6	0.1	0.1	0.1	0.1	0.4	0.1
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 72.0"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HHSteC: 1.9;SK-BR-3: 5.4;SK-MEL-30: 1.7;U-2197: 9.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.7	0.6	0.1	0.1	16.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.2	0.1	72.0	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.7	1.0	0.0	0.0	0.0	0.2	9.5	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699307-49792921	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 71.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046852	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA046852: AB_2679840"	"unprognostic (4.20e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	12.4	8.0	15.2	9.1	11.8	14.1	12.4	10.9	14.4	8.5	11.4	7.5	8.1	7.0	9.5	6.8	14.5	7.3	8.4	17.2	12.3	11.4	8.0	13.6	9.6	9.4	11.1	11.4	8.1	6.3	9.1	8.1	8.3	13.0	9.4	9.7	5.9	8.3	11.4	71.8	9.0	8.5	14.3	13.2	8.1	8.3	15.1	11.8	11.4	10.9	14.6	10.8	15.0	16.3	6.0	5.0	7.6	6.8	8.1	12.1	4.1	13.8	9.6	18.5	15.4	18.9	20.9	9.3	25.3	20.9	22.2	16.2	29.1	13.0	29.9	5.2	29.3	16.4	22.0	20.3	37.1	17.9	15.4	21.9	9.5	33.9	18.5	32.7	14.2	15.3	14.7	18.6	24.6	27.4	12.1	8.1	30.6	6.3	17.5	17.8	21.3	6.8	23.0	18.2	9.1	13.6	11.5	7.8	12.4	9.2	11.6	10.0	6.8	13.2	24.8	16.5	13.4	15.0	16.8	6.6	9.2	26.4	10.0	15.1	16.3	7.6	4.6	4.3	8.6	5.5	12.1	6.0	8.8	8.4	5.0	4.0	8.8	7.9	2.8	8.1	6.8	2.9	10.1	4.1	15.2	11.8	10.9	14.4	12.3	11.4	11.1	11.4	13.0	11.8
MYBPC1		ENSG00000196091	"Myosin binding protein C, slow type"	Q00872	12	101568353-101686018	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 739.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;HSkMC: 3.3;SCLC-21H: 1.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Group enriched"	"Detected in some"	9	"cerebellum: 41.6;olfactory region: 12.2"	"Low region specificity"	"Detected in all"			"HPA021004, HPA027614"	Enhanced									"HPA021004: AB_1854232, HPA027614: AB_10602711"	"prognostic favourable (4.76e-5)"	"unprognostic (7.72e-2)"	"unprognostic (1.09e-1)"		"unprognostic (1.81e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.55e-3)"	10.4	0.1	0.2	0.1	0.2	0.1	3.3	0.1	0.6	0.2	0.3	0.0	0.0	0.1	0.1	20.1	6.2	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	4.5	0.1	0.0	8.1	0.1	739.9	0.2	0.5	0.1	0.2	0.1	0.2	0.3	0.0	0.0	2.7	164.9	9.7	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.6	0.2	0.2	0.2	0.0	0.0	0.0
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175813	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 53.8"	"Group enriched"	"Detected in some"	5	"CACO-2: 17.2;HSkMC: 33.7;THP-1: 8.4"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA061383: AB_2684497"	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.8	0.1	1.1	0.8	0.8	0.3	0.4	0.4	0.6	0.1	0.1	0.0	0.0	0.1	0.4	4.4	3.9	0.2	0.1	0.2	0.4	0.3	1.1	1.5	0.2	0.3	1.3	0.0	0.1	0.2	0.1	0.6	0.3	1.0	4.2	0.1	0.0	8.8	0.1	53.8	0.2	0.1	0.1	0.4	0.4	0.1	0.2	2.1	0.9	3.9	12.7	2.0	0.3	0.8	0.0	6.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	1.1	0.8	0.4	0.6	0.4	0.3	1.3	0.0	1.0	2.1
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324122-46445769	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 82.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 10.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7"	"Low region specificity"	"Detected in all"							"HPA016820, HPA019887, HPA032101"	Enhanced		Enhanced	Centrosome				Centrosome	Centrosome	"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151"	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	4.7	4.7	16.6	6.9	20.4	12.6	3.6	8.3	16.5	3.2	4.0	4.4	3.8	3.7	3.7	4.1	5.1	3.4	5.0	8.2	12.0	4.2	3.2	4.4	4.3	6.4	7.0	9.7	4.9	3.3	5.9	8.0	3.4	5.6	4.0	4.1	2.0	4.1	4.1	82.3	10.4	4.0	4.2	4.3	5.5	4.6	14.5	9.7	9.1	4.4	2.2	4.8	4.7	5.1	0.4	5.3	4.9	1.2	0.5	10.7	2.3	9.2	7.3	11.3	6.9	5.7	5.8	7.1	7.2	5.0	7.2	6.4	8.8	6.0	9.3	4.6	8.2	6.7	9.1	6.2	5.0	27.0	12.8	24.6	13.6	6.8	1.9	12.4	10.2	3.1	4.7	9.6	4.8	5.5	12.4	14.0	9.8	15.4	12.2	12.8	11.2	5.0	15.2	4.6	8.1	5.6	10.0	13.9	6.2	15.5	9.7	4.7	9.2	9.7	7.5	12.9	6.5	7.3	11.4	12.1	10.1	10.0	8.0	12.2	6.9	4.9	0.8	1.3	2.0	0.6	5.9	0.4	0.9	5.9	2.3	0.2	0.7	10.7	0.5	0.5	1.2	5.3	0.9	2.3	16.6	20.4	8.3	16.5	12.0	4.2	7.0	9.7	5.6	9.7
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		20000000	20000000	Cytosol	Cytosol	"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: "	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	30.2	12.7	4.8	15.7	31.7	23.4	38.9	12.5	17.0	13.6	22.3	10.5	14.1	9.6	26.2	19.2	7.2	6.6	26.3	16.1	11.7	8.8	20.2	21.5	10.8	26.2	17.7	1.2	29.5	17.0	15.9	25.2	8.1	0.0	12.8	21.8	1.8	5.1	9.7	21.8	20.4	7.2	22.3	3.1	19.8	9.5	2.9	18.7	27.3	28.6	41.6	8.9	6.7	0.8	20.2	10.3	17.9	10.6	8.1	11.9	15.6	33.0	15.6	8.6	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5
PGPEP1L		ENSG00000183571	"Pyroglutamyl-peptidase I-like"	A6NFU8	15	98968230-99007795	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 34.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;U-2 OS: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"basophil: 2.0;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"					"Not detected"	"Not detected"			HPA041781	Uncertain									"HPA041781: AB_10795642"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-2)"		"unprognostic (8.26e-2)"	"unprognostic (2.43e-3)"	"unprognostic (7.18e-2)"		"unprognostic (3.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.65e-1)"	0.7	0.1	0.5	0.2	1.4	0.1	0.6	0.2	0.5	0.4	0.4	0.4	0.0	0.2	0.2	0.4	0.8	0.2	0.5	3.6	0.6	0.4	0.4	0.0	0.2	0.3	0.4	0.2	0.2	0.5	0.0	0.1	0.3	0.4	0.6	0.0	1.6	0.9	0.5	34.7	0.1	0.2	0.3	0.3	0.1	0.2	5.0	0.2	0.1	0.1	8.6	0.5	0.2	0.3	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.7	0.0	0.2	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	1.9	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.9	1.4	0.1	0.0	0.2	0.4	1.3	0.4	0.4	0.1	1.2	0.0	0.9	0.3	0.4	0.5	1.4	0.2	0.8	0.0	0.7	0.0	4.4	0.2	0.1	0.8	0.2	0.7	0.0	0.5	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.2	0.5	0.6	0.4	0.4	0.2	0.4	0.2
RRAD	"RAD, REM3"	ENSG00000166592	"RRAD, Ras related glycolysis inhibitor and calcium channel regulator"	P55042	16	66921679-66925644	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 246.0"	"Group enriched"	"Detected in some"	8	"HDLM-2: 60.8;U-87 MG: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041755	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA041755: AB_2677655"	"unprognostic (1.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.46e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.80e-3)"	7.3	2.1	0.4	2.4	2.7	1.3	5.0	1.2	1.7	4.7	2.0	3.2	1.8	1.2	3.3	8.5	20.4	6.3	4.1	61.2	0.7	0.6	5.6	0.8	6.3	1.3	1.5	0.8	4.7	0.7	1.0	2.0	10.7	4.6	4.2	0.4	3.9	4.3	1.4	246.0	2.2	1.2	5.7	1.7	0.8	1.7	2.3	1.2	0.3	3.9	14.7	4.3	4.5	5.7	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	2.8	0.0	0.0	0.0	0.3	0.1	1.6	0.1	0.2	1.4	0.6	1.9	0.0	1.6	0.1	0.1	0.0	0.1	0.2	60.8	0.1	0.0	0.0	0.7	2.7	0.0	0.2	0.8	0.3	4.9	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.7	1.2	1.0	0.7	0.6	1.5	0.8	4.6	1.2
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433699-38587564	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 231.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;monocytes: 6.3"	"Low region specificity"	"Detected in some"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	5.3	0.7	3.0	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0.0	0.4	0.4	6.7	3.0	0.6	0.5	0.4	1.8	4.0	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231.0	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0.0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0.0	0.6	0.6	0.0	5.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.0	0.3	0.3	4.7	0.0	13.7	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.4	1.3	5.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	11.3	1.0	0.6	0.0	0.0	1.1	22.3	0.0	0.0	0.5	4.2	0.0	0.0	9.4	0.2	0.0	0.3	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0.0	0.0	0.1	0.0	6.3	0.0	0.6	0.6	3.0	1.9	2.7	1.7	1.8	4.0	1.5	1.3	1.9	1.9
SMTNL2	FLJ42461	ENSG00000188176	"Smoothelin like 2"	Q2TAL5	17	4583999-4608319	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 99.7"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 32.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (8.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.73e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.89e-2)"	"prognostic favourable (1.28e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.22e-1)"	3.0	0.1	0.1	0.5	0.2	0.1	0.5	0.1	0.5	1.0	0.3	0.0	0.0	0.1	0.9	4.7	3.4	1.8	2.4	4.8	0.8	0.1	17.9	0.1	1.0	0.1	0.1	0.0	5.3	0.1	0.2	0.6	1.4	0.1	2.7	0.2	0.1	1.4	0.4	99.7	0.2	0.2	2.1	0.1	0.2	0.3	0.6	0.0	0.0	0.8	24.6	1.1	3.3	0.7	0.0	0.4	0.0	2.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	32.1	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.4	0.0	1.9	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.6	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.5	0.8	0.1	0.1	0.0	0.1	0.0
SRPK3	"MSSK1, STK23"	ENSG00000184343	"SRSF protein kinase 3"	Q9UPE1	X	153776412-153785732	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skeletal muscle: 73.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 30.8;U-266/70: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.47e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.10e-4)"	"unprognostic (8.70e-2)"	"unprognostic (5.38e-7)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.07e-4)"	1.6	1.8	1.3	0.9	1.8	0.8	0.3	7.7	1.5	0.9	4.5	1.1	0.2	1.3	2.5	3.3	2.6	0.7	1.7	16.7	2.0	1.8	0.2	0.2	0.4	0.8	2.0	0.7	0.7	0.7	1.0	5.8	0.3	1.1	2.8	0.8	0.9	2.9	0.5	73.4	2.3	1.3	4.0	2.0	0.8	1.3	0.5	0.9	0.3	0.6	18.3	1.6	2.0	0.8	0.4	2.6	0.9	0.3	0.1	0.6	0.3	3.2	4.3	0.7	2.2	0.0	0.1	1.0	0.4	0.0	0.2	0.0	3.6	0.6	3.2	0.4	0.3	0.9	0.0	0.1	0.0	2.8	3.0	1.7	2.7	0.5	0.0	0.8	5.0	2.7	0.0	0.0	0.0	0.0	2.1	3.8	0.8	6.9	0.6	4.7	0.8	1.2	1.5	30.8	0.9	0.0	1.4	5.2	2.5	0.0	2.3	1.0	2.9	3.7	0.0	1.2	2.8	2.3	0.4	12.8	2.0	2.2	0.6	6.1	1.6	0.8	0.3	0.2	0.5	0.1	0.6	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.1	0.0	2.6	0.0	0.3	1.3	1.8	7.7	1.5	2.0	1.8	2.0	0.7	1.1	0.9
TMOD4	Sk-Tmod	ENSG00000163157	"Tropomodulin 4"	Q9NZQ9	1	151169986-151176284	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 153.5"	"Cell line enhanced"	"Detected in many"		"HEK 293: 6.4;NB-4: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdTCR: 1.5;memory B-cell: 1.7;memory CD4 T-cell: 1.5;naive B-cell: 1.0;naive CD4 T-cell: 1.6;naive CD8 T-cell: 3.5;plasmacytoid DC: 1.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;dendritic cells: 1.0;T-cells: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028203	Enhanced									"HPA028203: AB_10600830"																		2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	4.0	1.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	1.6	0.1	153.5	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.3	35.0	1.6	0.4	0.1	1.7	1.0	0.4	0.3	0.0	3.5	0.6	0.5	0.4	0.9	0.1	0.7	0.2	1.6	0.1	0.6	0.4	0.1	0.0	0.6	1.4	0.7	1.6	0.5	1.4	0.3	0.5	2.7	6.4	2.6	2.2	0.0	1.0	1.4	3.2	0.0	0.4	1.2	3.0	0.8	1.6	2.3	0.2	2.3	0.7	8.0	1.4	2.6	2.5	0.3	0.1	0.5	1.5	1.8	1.1	0.7	0.0	0.1	0.8	4.9	1.0	0.2	1.1	2.3	0.7	2.9	5.5	1.2	0.8	4.4	0.6	0.0	0.3	0.4	1.5	0.0	0.4	1.7	1.5	0.2	0.1	1.0	1.6	3.5	0.2	0.0	0.3	1.0	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
UBAC1	"GBDR1, KPC2, UBADC1"	ENSG00000130560	"UBA domain containing 1"	Q9BSL1	9	135932969-135961380	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 113.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 59.3;K-562: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005651	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		54000	54000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA005651: AB_1858489"	"unprognostic (8.41e-2)"	"prognostic favourable (4.34e-6)"	"unprognostic (2.10e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.85e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.58e-7)"	"unprognostic (1.95e-3)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	7.6	5.7	12.4	5.8	13.4	27.1	6.2	10.9	12.7	6.1	11.0	8.0	6.8	9.9	6.2	10.3	10.0	9.4	5.1	22.2	11.0	8.6	8.8	7.6	6.4	5.8	11.6	7.4	7.8	6.7	6.9	6.6	9.3	8.7	7.4	7.8	7.7	9.2	9.2	113.2	15.7	9.6	9.3	10.1	5.7	6.1	10.9	7.8	3.9	6.1	21.9	9.0	7.6	8.3	3.2	9.7	5.1	18.8	2.2	3.6	4.0	8.9	10.5	7.5	10.8	5.6	6.6	14.0	7.9	6.7	9.8	7.9	14.5	11.5	10.8	7.6	6.4	30.7	10.4	9.1	4.4	59.3	9.8	9.0	18.9	8.1	5.9	11.7	8.7	6.2	12.0	6.2	6.0	8.1	75.2	8.8	7.7	18.5	9.6	12.1	17.7	17.9	10.8	14.1	14.3	7.0	5.8	11.6	12.8	11.4	10.3	8.0	8.7	12.7	6.6	5.6	8.4	6.6	9.7	5.1	9.6	12.9	10.3	10.7	7.6	3.4	11.3	5.1	3.1	17.2	3.3	3.2	3.6	2.1	9.7	2.0	1.9	2.2	2.5	2.2	18.8	1.0	2.7	4.0	12.4	13.4	10.9	12.7	11.0	8.6	11.6	7.4	8.7	7.8
